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ABSTRACT 
Biology of maintenance and de novo methylation mediated by DNA methyltransferase-1 
Olga Yarychkivska 
 
Within the past 70 years since the discovery of 5-methylcytosine, we have acquired 
considerable knowledge about genomic DNA methylation patterns, the dynamics of DNA 
methylation throughout development, and the enzymatic machinery that establishes and 
perpetuates genomic methylation patterns. Nonetheless, in the field of epigenetics major 
questions remain open about the mechanisms of spatiotemporal control that exist to ensure the 
fidelity of methylation patterns. This thesis aims to decipher the regulatory logic and upstream 
pathways influencing one of the DNA methyltransferases by leveraging the diverse resources of 
molecular genetics, biochemistry, and structural biology.  
The primary subject of my research, DNA methyltransferase 1 (DNMT1), is crucial for 
maintaining genomic methylation patterns upon DNA replication and cell division. In addition to 
its C-terminal catalytic domain, mammalian DNMT1 harbors several N-terminal domains of 
unknown function: a succession of seven glycine-lysine (GK) repeats, resembling histone tails, 
and two Bromo-Adjacent Homology (BAH) domains that are absent from bacterial DNA 
methyltransferases. The work I present in this thesis characterizes the role of these hitherto 
enigmatic domains in regulating DNMT1 activity. 
In my studies, I found that mutation of the (GK) repeats motif leads to de 
novo methylation by DNMT1 specifically at paternally imprinted genes. Conventionally, de 
novo methylation is thought to be undertaken by complete different enzymes, DNMT3A and 
DNMT3B, whereas DNMT1 is limited to perpetuating the patterns these other 
methyltransferases had set down. Recombinant DNMT1 had been previously shown to 
efficiently methylate unmethylated DNA substrate in vitro, but this is the first time its de 
novo methyltransferase capability has been observed in vivo. Based on these data, I propose a 
new model in which DNMT1 is the enzyme responsible for laying down de novo methylation 
patterns at paternally imprinted genes in the male germline, explaining the previously observed 
non-essential role of other DNA methyltransferases in the establishment of paternal imprints. 
Furthermore, I demonstrated that acetylation of the (GK) repeats motif inhibits this de 
novo methyltransferase activity of DNMT1, making this particular motif an essential regulatory 
platform for controlling the diverse in vivo functions of the enzyme. 
Though the (GK) repeats motif had previously been proposed to regulate the stability of 
DNMT1 protein through its interaction with the deubiquitinase USP7, I tested the biological 
relevance of this interaction and found that USP7 deletion does not alter DNMT1 protein levels. 
In fact, USP7 appears to play no part in regulating maintenance DNA methylation, as I present 
evidence that USP7 localization to replication foci is entirely independent of DNMT1. 
Finally, I demonstrated that the tandem BAH domains of DNMT1 are required for its 
maintenance methyltransferase activity as they are involved in targeting the enzyme to 
replication foci during S phase. Based on biochemical data supporting an interaction between 
DNMT1's BAH1 domain and histones, I propose that this targeting could occur through BAH1's 
recognition of specific histone modifications, thus providing a potential mechanistic link 
between maintenance DNA methylation and chromatin markings. 
This thesis identifies DNMT1 as a novel de novo methyltransferase in vivo and also 
characterizes the regulatory functions of the enzyme's BAH domains and the (GK) repeats. These 
results elucidate the multiple regulatory mechanisms within the DNMT1 molecule itself that 
control its functions in mammalian cells, thereby providing critical insights as to how the DNA 
methylation landscape takes shape and yielding surprising revelations about the parts that well-
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CHAPTER I.  GENERAL INTRODUCTION 
 
The existence of DNA methylation at cytosine residues has been known for almost 70 
years (HOTCHKISS 1948). In 1948, Hotchkiss first discovered 5-methylcytosine in calf thymus 
preparation using paper chromatography by observing that this novel nucleotide separated from 
cytosine in the same manner that thymine (also known as methyluracil) separated from uracil 
(HOTCHKISS 1948). Biochemical studies with deoxyribonucleic and ribonucleic acids and cell 
extracts showed that DNA polymerase has no ability to distinguish between 5-methylcytosine 
and cytosine (Gold et al. 1963; Bessman et al. 1958), suggesting that addition of a small methyl 
group to cytosine does not block DNA replication nor, most likely, transcription.  
 More than 40 years ago, scientists first predicted the existence of two general classes of 
DNA methyltransferases: de novo enzymes that would establish methylation patterns during 
embryonic development, and maintenance enzymes that would replicate methylation patterns 
during cell division by methylating hemimethylated CpG sites produced by semiconservative 
DNA replication (Riggs 1975; Holliday & Pugh 1975). This prediction has since been 
experimentally confirmed. In 1981, it was demonstrated that cytosine methylation patterns on an 
artificially methylated plasmid transfected into mouse cells can be stably maintained for up to 25 
cell divisions (Wigler et al. 1981). In 1988, the first mammalian enzyme involved in DNA 
methylation, DNA methyltransferase 1 (DNMT1), was cloned and sequenced (Bestor et al. 
1988); to date, it remains the only known maintenance methyltransferase. It took another 10 
years after this work before the de novo methyltransferases DNMT3A and DNMT3B were 
cloned and characterized (Okano et al. 1998).  
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 In 2011, the first crystal structure of DNMT1 with DNA was solved (Song et al. 2011), 
providing the basis for elucidation of the molecular mechanisms of maintenance DNA 
methylation as well as DNMT1’s regulatory interactions. This thesis aims to further expand our 
knowledge about the maintenance DNA methyltransferase DNMT1, specifically its regulation by 
N-terminal domains of previously unknown function: the lysine-glycine (GK) repeats and Bromo 





I. 1. Patterns and Machinery of DNA Methylation 
a. Overall composition of the mammalian genome 
The mammalian genome is mainly populated by repeat sequences and transposable 
elements (Rollins et al. 2006; Waterston et al. 2002), and fully half consists of autonomous 
retrotransposons (LTR and non-LTR), non-autonomous retrotransposons and DNA transposons 
(Kazazian 2004) (Figure 1A). 
Autonomous LTR retrotransposons include intracisternal A-particles (IAPs), which are 
the most active retrotransposons in the mouse genome (Kazazian 2004). There are about 1,000 
distinct IAP elements in the mouse genome, one third of which are functional and capable of 
autonomous retrotransposition (Dewannieux et al. 2004). Autonomous non-LTR 
retrotransposons include long interspersed elements (LINEs), present in almost all eukaryotes, 
which contain a 5’ promoter region and two open reading frames that encode proteins necessary 
for retrotransposition (Smit, 1996). Non-autonomous retrotransposons include short interspersed 
elements (SINEs) that lack a functional reverse transcriptase but can be mobilized in trans by 
LINEs (Kazazian 2004). Other repeat elements in the mouse genome are pericentromeric major 
satellites and centromeric minor satellites (Lehnertz et al. 2003).  
 LTR retrotransposons and DNA transposons make up 9.3% and 3.6% of the human 
genome respectively, while LINEs and SINEs constitute 22.3% and 16.1% (Rollins et al. 2006). 
While about 40% of the genome is composed of unnanotated and intergenic compartments, the 
remaining genomic sequences constitute only a small fraction of the entire genome: simple and 
other repeats – 3.15%, satellites – 4.17%, exons – 2.14%, and isolated CpG islands – 0.57% 
(Rollins et al. 2006).  
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CpG dinucleotides are not equally distributed across the mammalian genome. The 
majority of CpG dinucleotides in the human genome are found in the unannotated compartment 
(30.4%) and in SINEs (27.2%), while CpG islands, both isolated and those associated with gene 
promoters, account for 6.8% of genomic CpG dinucleotides (Rollins et al. 2006). Interestingly, 
even though LINEs make up a greater proportion of the human genome than SINEs, they contain 
a lower number of CpG sites. This is due to the fact that LINEs are older retrotransposons 
compared to SINEs and, therefore, have endured a longer time period and more opportunities for 




FIGURE 1A. Composition of the human genome and distribution of DNA methylation. (Figure 
adopted from John Edwards). Vertical axis indicates percentage of total CpG dinucleotides in 
each compartment; horizontal axis indicates percentage of total genome in each compartment, 
light blue at the top of each compartment indicates unmethylated fraction. Unmethylated 
compartment of CpG islands/first exons occupies <0.5% of the genome. The ICR/DMR 





FIGURE 1B. De novo versus maintenance activities of DNA methyltransferases. (Adopted from 
Okano et al. 1998). Baculovirus expressed DNMT3A, DNMT3B and His-tagged DNMT1 were 
incubated with double-stranded unmethylated and hemimethylated oligonucleotides. DNMT1 





b. Methylation patterns and different genomic compartments 
Advances in next-generation sequencing technologies have allowed for more precise 
genome-wide analysis of mammalian cytosine methylation patterns and understanding of the 
genomic compartments prone to CpG methylation or resistant to methylation. Multiple 
approaches have been developed to this end, including immunoprecipitation of methylated DNA 
followed by massive sequencing or hybridization onto an array, known as MeDIP-seq 
(Maunakea et al. 2010); parallel sequencing of bisulfite-treated DNA (Lister et al. 2009); 
enzymatic fractionation of the genome into methylated and unmethylated compartments 
followed by deep sequencing, called MethylMAPS (J. R. Edwards et al. 2010); and reduced 
representation bisulfite sequencing, or RRBS (Meissner et al. 2005). Three principal findings are 
common across all of the genome-wide methylation studies: 1) repeat elements are heavily 
methylated in mammals, regardless of the studied tissue; 2) CpG-dense regions (CpG islands) are 
unmethylated; and 3) gene bodies of transcriptional units exhibit elevated methylation levels 
relative to surrounding intergenic regions (Figure 1A).  
Each genomic compartment exhibits specific correlation between CpG methylation and 
CpG density up to a certain threshold (Rollins et al. 2006; J. R. Edwards et al. 2010). Repeat 
elements are hypermethylated (about 80% methylated in human and mouse), with the exception 
of simple repeats (Rollins et al. 2006; J. R. Edwards et al. 2010). This observation is consistent 
with the role of cytosine methylation in silencing transposons in vertebrates (Bestor 2003). 
Within repeat elements, methylation levels increase as local CpG density increases, up to a 
density of 1 per 15 nucleotides, beyond which methylation levels decrease significantly (J. R. 
Edwards et al. 2010).  
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The majority of CpG-dense promoters are kept unmethylated (Meissner et al. 2008; 
Mohn et al. 2008; Zemach et al. 2010; J. R. Edwards et al. 2010) (Figure 1A). Interestingly, 
CpG-dense domains outside the repeats, including those within promoters, show increased 
methylation levels up to a density of 1 in 40 nucleotides, which is a significantly lower 
methylation density than that of repeat sequences (J. R. Edwards et al. 2010). This suggests that 
the refractory nature of CpG islands is not fixed by nucleotide content alone but involves 
additional factors that protect them from methylation. Consistent with this observation, FBXL10 
has been discovered as a required factor that protects CpG islands co-occupied by Polycomb 
repressive complexes from acquisition of methylation (Boulard et al. 2015).  
Internal introns and exons show high levels of methylation, with exons displaying higher 
methylation levels and CpG density (J. R. Edwards et al. 2010). This observation demonstrates 
that, in mammals, gene bodies exhibit high levels of methylation that correspond to local CpG 
density. To date, the significance of exonic methylation remains unclear. 
Overall, these studies and observations demonstrate the importance of taking into account 
the type of sequences studied and CpG density within these sequences when studying DNA 
methylation. For example, while 75% of all promoters are located within CpG islands (Ioshikhes 
& M. Q. Zhang 2000), the remaining promoters have very low CpG densities and methylation is 
unlikely to regulate their expression. 
 
c. DNA methyltransferases 
Mammals use three catalytically active DNA methyltransferases to regulate DNA 
methylation levels: DNMT1, DNMT3A and DNMT3B (Okano et al. 1998; Bestor et al. 1988) as 
well as a co-factor DNMT3L that is itself devoid of catalytic activity and is expressed 
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exclusively in the germline (Bourc'his et al. 2001; Bourc'his & Bestor 2004). Recently, a rodent-
specific DNA methyltransferase called DNMT3C has been identified (Barau et al. 2016). 
Dnmt3c evolved as a duplication of Dnmt3b and is responsible for methylation of evolutionarily 
young retrotransposons in the male germline, which is required for mouse fertility (Barau et al. 
2016).  
Dnmt3a and Dnmt3b are closely related genes, sharing a common domain composition 
formed by a PWWP domain, a PHD-like domain and a C-terminal DNA methyltransferase 
domain (Okano et al. 1998; Otani et al. 2009; Qiu et al. 2002). The human genes display high 
amino acid conservation in the catalytic C-terminal domain with 81% sequence identity between 
them, though only having 30% identity in the variable N-terminal domain (S. Xie et al. 1999) .  
DNMT3A and DNMT3B are required to initiate methylation of unmethylated DNA 
template in vivo, as shown by the inability of embryonic stem cells deleted for both Dnmt3a and 
Dnmt3b (hereafter Dnmt3ab
-/-
) to methylate a newly integrated retroviral fragment, despite the 
presence of DNMT1 (Okano et al. 1999). Based on this evidence, de novo genomic methylation 
is thought to be exclusively catalyzed by DNMT3A and DNMT3B, even though DNMT1 
exhibits higher activity on unmethylated DNA in vitro than both DNMT3A and DNMT3B 
(Okano et al. 1998) (Figure 1-B). DNMT3A and DNMT3B share redundant de novo DNA 
methylation activity in some genomic compartments, such as retroviral DNA or interspersed 
repeats (T. Chen et al. 2003; T. Chen et al. 2004; Okano et al. 1999). Both DNMT3A and 
DNMT3B show strong association with chromatin, the nucleoprotein complex consisting of 
DNA and histone proteins (Jeong et al. 2009). 
Although DNMT3A and DNMT3B cooperate and interact together, they are generally 
expressed at different levels in a given cell type, suggesting incomplete overlap of functions 
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(Okano et al. 1998) (Kashiwagi et al. 2011) . Indeed, DNMT3B has a non-redundant activity on 
pericentromeric tandem repeats (satellite sequences) (T. Chen et al. 2003; T. Chen et al. 2004; 
Okano et al. 1999); DNMT3A is not able to compensate this function when reintroduced into 
Dnmt3ab
-/-
 embryonic stem cells (T. Chen et al. 2003; T. Chen et al. 2004). 
Despite strong structural similarities in the C-terminus, DNMT3A and DNMT3B differ in 
the N-terminus. These differences include the PWWP domain, shown to be important for 
DNMT3B-directed methylation of pericentromeric repeats (T. Chen et al. 2004). Notably, the 
PWWP of DNMT3B was shown to bind DNA, whereas the slightly different PWWP of 
DNMT3A does not, indicating that the binding of either DNMT3A or DNMT3B to specific loci 
is mediated in part by the PWWP domain (T. Chen et al. 2004; Qiu et al. 2002).  
In addition, DNMT3B preferentially associates with H1-containing condensed chromatin 
(Kashiwagi et al. 2011). Co-sedimentation experiments have shown that DNMT3B is released 
from polynucleosomes containing less that 5 nucleosomes, indicating that DNMT3B association 
with chromatin is mediated by higher-order chromatin structure (Kashiwagi et al. 2011).  
Loss of function genetics in mouse has revealed many differences between Dnmt3a and 
Dnmt3b. Dnmt3a mutants develop normally, but die at 4 weeks of age; hence Dnmt3a seems to 
be important for survival but not for embryonic development (Okano et al. 1999). In contrast, 
loss-of-function of Dnmt3b results in embryonic lethality and is characterized by partial 
demethylation, mainly at pericentromeric tandem repeats (Okano et al. 1999). Mutations in the 
Dnmt3b gene cause an autosomal recessive developmental disorder in humans called ICF 
syndrome (immunodeficiency, centromeric instability, facial anomalies) (G. L. Xu et al. 1999). 
Affected individuals have centromeric heterochromatin instability at chromosomes 1, 9 and 16 
caused by hypomethylation of classic satellites II and III (G. L. Xu et al. 1999) and exhibit 
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hypomethylation of subtelomeric regions as well as decreased length of telomeres (Yehezkel et 
al. 2008). ICF mutations of Dnmt3b are not complete loss-of-function mutations and do not 
abolish catalytic activity of DNMT3B (Ueda et al. 2006), but they prevent the interaction 
between DNMT3B and DNMT3L (Z.-H. Xie et al. 2006). This impairment of DNMT3B 
recruitment causes the significant developmental abnormalities seen in ICF syndrome.  
DNMT1 is the only known maintenance DNA methyltransferase (Bestor et al. 1988; E. 




I.2. Functions of DNA methylation 
a. Defense against transposable elements 
In mammals, cytosine methylation in a CpG context plays a crucial role for the restriction 
of transposons and other parasitic elements that threaten the integrity of the genome (Smit 1996; 
Bestor 2003).The potential of DNA methylation to silence transposons was first demonstrated by 
transient transfection assays of an artificial IAP element in which in vitro methylation at the LTR 
was sufficient to inhibit the expression of the IAP element (Feenstra et al. 1986). Since then 
accumulating genetic evidence has demonstrated that DNA methylation is necessary and 
sufficient for the silencing of parasitic elements (Bourc'his & Bestor 2004; Tsumura et al. 2006; 
Walsh et al. 1998). The first observation of retrotransposon activation following reduction of 
genomic methylation levels came from the study of Dnmt1-null mouse embryos, where IAP 
expression was massively reanimated (Walsh et al. 1998). The catalytic activity of DNMT1 was 
shown to be crucial for the silencing of IAP elements (Damelin & Bestor 2007). Dnmt1-
conditional deletion demonstrated that DNA methylation is also necessary for repression of IAPs 
in differentiated cells (Jackson-Grusby et al. 2001). The essential role of DNA methylation for 
transposon silencing has been further illustrated using Dnmt3l loss-of-function mutant males that 
exhibit severe hypomethylation at interspersed repeats (IAP and LINEs) in the germline 
(Bourc'his & Bestor 2004). This hypomethylation induces transcription of those elements, causes 
meiotic catastrophe and, as a consequence, complete male sterility (Bourc'his & Bestor 2004). 
 
b. Genome stability and apoptosis 
Loss of DNA methylation in differentiated cells results in genome instability and cell 
death (Jackson-Grusby et al. 2001; Dodge et al. 2005). Global genomic demethylation resulting 
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from Dnmt1-conditional disruption in murine embryonic fibroblasts (MEFs) induces cell death 
by apoptosis (Jackson-Grusby et al. 2001). Similarly, global demethylation of the human cancer 
cell line HCT1168, induced by conditional deletion of Dnmt1, leads to G2 arrest followed by 
progressive cell death (T. Chen et al. 2007). Moreover, Dnmt1-deficient embryonic stem cells 
(ESCs) rapidly die when induced to differentiate  (E. Li et al. 1992; Panning & Jaenisch 1996). 
Cell death of differentiating Dnmt1-null ESCs occurs even when a catalytically inactive DNMT1 
is re-introduced into the cell (Damelin & Bestor 2007)  showing that apoptosis is triggered by the 
loss of DNA methylation rather than by the absence of DNMT1 protein. These experiments 
show that there is an absolute necessity for differentiated cells to maintain DNA methylation 
levels above a certain threshold in order to survive. While mouse ESCs are not affected by the 
loss of DNA methylation and grow normally when all three DNA methyltransferases 
(DNMT3A, DNMT3B, DNMT1) are deleted (Tsumura et al. 2006), human ESCs exhibit 
massive cell death upon deletion of DNMT1 while remaining unaffected by disruption of 
DNMT3A and DNMT3B (Liao et al. 2015). This observation reflects that 1) deletion of DNMT1 
yields a more severe demethylation of the genome; and 2) mouse ESCs are known to be in a 
more naïve pluripotent state than human ESCs (Weinberger et al. 2016), such that they can 
survive severe demethylation. 
Simultaneous inactivation of both p53 and Dnmt1 in MEFs partially rescues the apoptotic 
phenotype (Jackson-Grusby et al. 2001), indicating that apoptosis resulting from loss of genomic 
methylation is both P53-dependent and -independent. The pathway by which loss of methylation 
activates apoptosis in differentiated cells remains to be determined.  
In addition to cell cycle arrest and cell death, demethylation in differentiated cells causes 
genomic instability (Bourc'his & Bestor 2004; T. Chen et al. 2007). Loss of methylation in 
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HCT1168 cells results in mitotic defects that include broken chromosomes, chromosome 
congressions or alignment defects (T. Chen et al. 2007). A similar DNA double strand break 
phenotype, characterized by the appearance of numerous foci of -H2A.X, has also been 
documented in Dnmt3l-deficient germ cells, in which demethylation of transposable elements is 
correlated with meiotic catastrophe (Bourc'his & Bestor 2004).  
 
c. Imprinting 
Parthenogenetic mouse embryos that contain only chromosomes of maternal origin fail to 
develop to term, indicating that a contribution of the paternal genome is crucial for mammalian 
embryonic development (Kaufman et al. 1977; Surani et al. 1984). This lethality has been 
associated with the impairment of the monoallelic expression of paternally imprinted genes (E. 
Li, Beard, Forster, et al. 1993), as evidenced by the live birth, normal development and normal 
reproductive ability of a parthenogenetic mouse carrying a 13-kb deletion in the H19 paternally 
imprinted gene in one of the maternal genomes (Kono et al. 2004). Experiments using transgenic 
mice have demonstrated that differential expression of paternally and maternally imprinted genes 
is a consequence of parent-of-origin specific DNA methylation (Reik et al. 1987; Sapienza et al. 
1987; Swain et al. 1987). Expression of imprinted genes is under the control of differentially 
methylated regions (DMRs) or imprints which serves as imprint control regions (ICRs) (Wutz et 
al. 1997; Thorvaldsen et al. 1998). One DMR often controls a cluster of co-regulated imprinted 
genes (Tomizawa et al. 2011); the 23 DMRs identified to date control monoallelic expression of 
some 130 genes (Duffié & Bourc'his 2013). The crucial role of DNA methylation for silencing 
one allele has been demonstrated using Dnmt1-deficient mice, in which imprinted genes become 
biallelically expressed (E. Li, Beard, Forster, et al. 1993). The oocyte-specific form of DNMT1 
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(DNMT1o) is important for imprint maintenance in 8-cell embryos (Howell et al. 2001), and the 
zygotic somatic form of DNMT1 (DNMT1s) is also required to maintain maternal and paternal 
imprints in the early embryo (Hirasawa et al. 2008). Similarly to parthenogenetic conceptuses, 
embryos depleted for Dnmt1 fail to develop beyond mid-gestation (E. Li et al. 1992) suggesting 
that proper maintenance of genomic imprints is essential for normal mammalian development. 
There are several notable differences between paternal and maternal DMRs. First, only 
three paternal DMRs are known (H19, Dlk1/Gtl2, and Rasgrf1), while about 20 maternal DMRs 
have been characterized to date (Duffié & Bourc'his 2013).  Second, paternal DMRs have lower 
CpG density than the maternal DMRs and are located in intergenic regions, while maternal 
DMRs lie within promoters (Kobayashi et al. 2006; Bourc'his & Bestor 2006). Third, paternal 
imprints are established early in the developing male germline around the time of birth, while 
maternal imprints are established in the growing oocyte shortly before ovulation (Bourc'his & 
Bestor 2006). Fourth, in addition to methyltransferases, different chromatin factors may be 
required for maternal versus paternal imprint establishment. For example, KDM1B, a histone H3 
lysine 4 demethylase is necessary for methylation of four maternal imprints (Ciccone et al. 
2009), while methylation of paternally imprinted Rasgrf1, but not of H19 or Dlk1/Gtl2, is 
dependent on PIWI (Watanabe et al. 2011). Differences in paternal and maternal imprinting 
further demonstrate a striking sexual dimorphism.  
Failure of correct imprint establishment can result in several developmental and cognitive 
disorders. Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are clinically distinct 
complex disorders that map to chromosome 15q11-q13 in human (chromosome 7 in mouse), 
which contains the imprinting cluster for Snurf/Snrpn (C. A. Edwards & Ferguson-Smith 
2007). Both disorders can result from microdeletion, uniparental disomy or a defect in the 
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imprint’s DMR, although Prader-Willi is caused by the loss of normal paternal contribution 
whereas Angelman syndrome is caused by the loss of normal maternal contribution (Cassidy et 
al. 2000). Specifically, SNRPN, a small nuclear ribonucleoprotein, is implicated in causation of 
Prader-Willi syndrome, while UBE3A, a ubiquitin ligase, is implicated in Angelman syndrome 
(Cassidy et al. 2000; C. A. Edwards & Ferguson-Smith 2007). The phenotypic consequence of 
these disorders resulting from defects in the same chromosomal region are strikingly different: 
Prader-Willi patients exhibit more severe behavioral and endocrine disorders including 
obsessive-compulsive symptoms and hypothalamic insufficiency, while Angelman syndrome 
patients have a more severe cognitive and neurologic impairment, including seizures and ataxia 
(Cassidy et al. 2000).  
 
d. X chromosome inactivation 
It has been shown that double dosage of X-linked genes is detrimental for extra-
embryonic development (Marahrens et al. 1997; Wang et al. 2001; Blewitt et al. 2008). In 
mammals, sex chromosome dosage compensation is achieved by inactivation of one of the two 
X-chromosomes in females (Okamoto & Heard 2009). Given random inactivation, female 
organisms are thus composed of a mosaic of cells that inactivate either the paternal or the 
maternal X-chromosome, while the extra-embryonic lineage specifically silences the paternal X-
chromosome (Okamoto & Heard 2009). Failure of paternal X-chromosome inactivation in the 
trophoblast causes lethality of female embryos (Marahrens et al. 1997; Wang et al. 2001; Blewitt 
et al. 2008). Given the absence of sexual dimorphism of mutants targeted for DNA 
methyltransferases, it is unlikely that genomic methylation plays an essential role in this process 
(E. Li et al. 1992; Okano et al. 1999). By using a reporter-transgene inserted into one of the X-
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chromosomes of female Dnmt1-mutant embryos, paternal X-chromosome imprinting (XCI) was 
shown to be independent of DNA methylation (Sado et al. 2000).  
XCI relies on the transcription of a non-coding RNA, Xist, from the future inactive X-
chromosome (Xi). Proper monoallelic expression of Xist, and subsequent X-inactivation have 
been reported to occur normally in the absence of DNA methyltransferases (Beard et al. 1995; 
Panning & Jaenisch 1996; Sado et al. 2004). However, cytosine methylation is important for the 
stable repression of Xist, since loss of methylation causes derepression of Xist in a fraction of 
cells (Panning & Jaenisch 1996; Sado et al. 2004). In addition, demethylation has been shown to 
induce Xist expression in male embryos (which normally do not express Xist), though 
demethylation does not reactivate Xist transcription in male undifferentiated ESCs (Beard et al. 
1995). This indicates that ESCs utilize mechanisms other than DNA methylation for Xist 
silencing. 
De novo methylation is dispensable for proper X-inactivation as evidenced by the normal 
expression level of X-linked genes in Dnmt3a- and Dnmt3b- null mutant mice (Sado et al. 2004). 
Nevertheless, more than half of the cells in Dnmt1-deficient female embryos express a transgene 
inserted in the paternal X-chromosome (Sado et al. 2000). Therefore, genomic methylation 
synergizes with the heterochomatin state of the Xi to impede transcription. Paradoxically, both 
male and female active X-chromosomes were reported to be hypermethylated outside of CpG 
islands (relative to the Xi) (Hellman & Chess 2007). Approximately half of the hypermethylated 
regions were found downstream of transcription start sites and exhibit no correlation with gene 




I.3. Methylation Dynamics 
a. Developmental overview  
DNA methylation patterns undergo drastic changes during early embryonic development in 
primordial germ cells (PGCs), which give rise to oocytes and spermatocytes, and in cleavage 
stage pre-implantation embryos (Monk et al. 1987), but later become very stable in all somatic 
tissues (Ziller et al. 2013).  
Global loss of methylation in PGCs takes place during their migration from the proximal 
epiblast to the gonadal ridge between E9.5-E11.5. However sequences that carry long-term 
epigenetic memory, such as imprints and CpG islands on the X chromosome, resist 
demethylation until PGCs enter the site of the future gonad (Seisenberger et al. 2012). While in 
general repeat elements are demethylated in PGCs, evolutionarily young an active 
restrotransposons (e.g. IAPs) are kept methylated to prevent their reactivation and parasitic 
transposition in the genomes of future germ cells (Seisenberger et al. 2012).  
Methylation patterns are re-established in PGCs with the endowment of sex-specific 
imprinting: this process is characterized by a profound sexual dimorphism in the identity and 
characteristics of sequences that acquire methylation and in the timing of de novo methylation 
(Schaefer et al. 2007). Acquisition of methylation is a premeiotic event in male germ cells, 
occurring perinatally in prospermatogonia, while in female germ cells it does not take place until 
oocytes are arrested in meiosis I shortly before ovulation (Schaefer et al. 2007). Establishment of 
sex-specific genomic methylation in the germline and role of DNMTs is discussed in greater 
detail in the following section. 
Cleavage stage embryos prior to implantation progressively lose methylation with each round 
of cell division, and, upon implantation, normal methylation is reconstituted globally (Howlett & 
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Reik 1991; Santos et al. 2002; Borgel et al. 2010; Z. D. Smith et al. 2012). Importantly, during 
the wave of early embryonic demethylation, both genomic imprints and CpG-rich transposons 
retain methylation (Morgan et al. 2005). Sequences that undergo demethylation in the pre-
implantation stage are primarily old and inactive transposon remnants, satellite repeats and 
unannotated genomic sequences.  
 
b. Establishment of sex-specific genomic methylation in the germline 
Novel patterns of genomic methylation are established in the germline by coordinated 
action of DNMT3A and its co-factor DNMT3L (Bourc'his et al. 2001; Bourc'his & Bestor 2004; 
Kaneda et al. 2004). Dnmt3l is homologous to the Dnmt3a/3b methyltransferases, as it carries the 
PHD-like domain, but lacks the methyltransferase domain and therefore is devoid of catalytic 
activity (Aapola et al. 2001). Conditional disruption of Dnmt3b in the gonads revealed that 
DNMT3B is dispensable for methylation in the gametes (Kaneda et al. 2004). 
While DNMT3A and DNMT3B are found in most tissues, Dnmt3l is specifically 
expressed in the germline at stages when de novo methylation occurs: in females it is present 
only in growing oocytes arrested in meiosis I, whereas in males it is expressed in diploid 
prospermatogonia (Okano et al. 1998; Bourc'his et al. 2001; Bourc'his & Bestor 2004). Deletions 
of Dnmt3a or Dnmt3l in the female germline produce phenotypically indistinguishable progeny 
(i.e. neural tube closure defects, pericardial edema, and extra-embryonic tissue abnormalities), 
with embryonic lethality at E9.5 (Bourc'his et al. 2001; Kaneda et al. 2004). The embryos lack 
maternal imprints and display biallelic expression of maternally imprinted genes. Therefore, both 
Dnmt3a and Dnmt3l are crucial for establishment of maternal imprints. Repeat elements show 
normal methylation patterns in the progeny from either Dnmt3a or Dnmt3l female mutants 
 19 
(Bourc'his et al. 2001; Kaneda et al. 2004). Hence, methylation at repeats is likely catalyzed by 
DNMT3B in the absence of DNMT3A, indicating that DNMT3B can substitute for DNMT3A to 
methylate both tandem and interspersed repeats. Furthermore, normal methylation of repeats in 
the progeny from Dnmt3l deficient mothers indicates that the recovery of full methylation of 
repeat elements in growing oocytes is independent of DNMT3L. 
Deletion of Dnmt3a or Dnmt3l in the male germline causes azoospermia and sterility 
(Bourc'his & Bestor 2004; Kaneda et al. 2004). In striking contrast to female germline, deletion 
of Dnmt3l results in demethylation and activation of both LTR (IAP) and non-LTR (LINE) 
retrotransposons, while H19 imprinted gene exhibits a minor loss of methylation and Dlk1/Gtl2 
has normal methylation (Bourc'his & Bestor 2004). Conditional deletion of Dnmt3b in male 
germline has no effect on paternal imprint methylation. The role of Dnmt3a in de novo 
methylation of paternal imprints is not well understood as variable methylation phenotypes have 
been reported after conditional disruption of Dnmt3a in the male germline (Kaneda et al. 2004; 
Kato et al. 2007). The importance of DNMT3A for paternal imprint establishment requires 
further investigation. Quite recently, it has been demonstrated that the newly discovered rodent-
specific de novo methyltransferase Dnmt3C is required for methylation of Rasgrf1 but not of 
H19 or Dlk1/Gtl2 (Barau et al. 2016). 
Dnmt3l is dispensable for female meiosis, but is required for male gamete development 
(Bourc'his & Bestor 2004). Even though Dnmt3l is not expressed during male meiosis, testes 
from adult mutants display severe hypogonadism and Sertoli cell-only phenotype(Bourc'his & 
Bestor 2004). Loss of Dnmt3l in males causes meiotic catastrophe characterized by asynapsis or 
abnormal synapsis (Bourc'his & Bestor 2004).  
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Although the mechanism by which DNMT3L stimulates DNA methylation is still 
unclear, the activation of DNMT3A/3B by DNMT3L was shown to be mediated by direct 
interaction as indicated by the binding of both DNMT3A2 and DNMT3B onto DNMT3L (Ooi et 
al. 2007). The C-terminal extremity of DNMT3L was shown to interact with the catalytic domain 
of DNMT3A and DNMT3B (Hata et al. 2002; Z.-X. Chen et al. 2005). In vitro DNMT3L 
strongly increases the binding of a methyl group donor S-adenosyl-L-methionine (SAM) to 
DNMT3A2 (Kareta et al. 2006), but DNMT3L does not bind to DNA itself. In addition, 
DMNT3L stimulates the catalytic activity of both DNMT3A and DNMT3B (Qiu et al. 2002; 
Suetake et al. 2004; Gowher, Liebert, et al. 2005). 
As such, the existing literature appears to be clear in establishing that methyltransferase 
DNMT3A and co-factor DNMT3L are required for methylation of maternally imprinted genes. 
However, DNMT3L is dispensable for de novo methylation of paternal ICRs, indicating that 
establishment of imprints in the male germline is mediated by other factors. 
 
c. Correlation with chromatin landscape  
Chromatin marks show greater correlation than do DNA sequences with the local DNA 
methylation profile (Zemach et al. 2010; Meissner et al. 2008; J. R. Edwards et al. 2010). Such 
interplays is not surprising given the recruitment of the DNMT3 family onto chromatin (Jeong et 
al. 2009; Nimura et al. 2006). Absence of DNA methylation does not influence the global levels 
of common histone modifications; however genome-wide distribution of histone modification 
has not been investigated in hypomethylated cells (Tsumura et al. 2006). 
The nucleosome is the basic organizational structure of chromatin; it consists of 146 
base pairs of DNA wrapped around a histone octamer composed of 2 molecules of H2A, H2B, 
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H3 and H4 (Luger et al. 1997). In contrast to acetylation, which reduces electrostatic interaction 
of histones with DNA, histone methylation has no effect on the nucleosomal structure. Instead, 
the methylation of histone tails is thought to modify the chromatin structure by recruitment of 
specific factors (B. Li et al. 2007). For example, the recruitment of DNMT3A onto the chromatin 
of transcribed regions could explain the presence of 5-methylcytosine downstream of 
transcription start sites. Indeed, a recent report shows that the PWWP domain of DNMT3A 
binds, with weak affinity, to methylated lysine 36 of histone H3 (H3K36me3) (Dhayalan et al. 
2010; Y. Zhang et al. 2010). The enrichment of H3K36me3 within actively transcribed genes 
could account for DNMT3A recruitment downstream of active promoters (B. Li et al. 2007). 
Other modifications of the nucleosome have been shown to influence genomic 
methylation patterns. These chromatin marks include the incorporation of the non-allelic variant 
H2A.Z (Zemach et al. 2010), the hypermethylation at lysine 9 of histone H3 (H3K9me3) 
(Lehnertz et al. 2003), the hypomethylation at lysine 4 of histone H3 (H3K4me0) (Ooi et al. 
2007; Meissner et al. 2008; Otani et al. 2009; J. R. Edwards et al. 2010) and the presence of the 
linker histone H1 (Fan et al. 2005). In addition, two ATP-dependant chromatin remodeling 
factors have been shown to play a role in the maintenance of DNA methylation: LSH and ATRX 
(Dennis et al. 2001; Garrick et al. 2006). 
The association of the histone H1 with the nucleosome promotes the formation of higher 
order structure of the chromatin fiber (Fan et al. 2005). ESCs targeted for the histone H1 display 
a specific loss of methylation at imprinted genes but not at repeat elements (Fan et al. 2005). 
Given the ubiquitous distribution of H1 within the nucleus, its presence is necessary but not 
sufficient to keep imprinted DMRs methylated. 
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 H3K9me3 is generally found in heterochromatin regions such as pericentromeric regions 
(B. Li et al. 2007). H3K9me3 was reported to be important for the localization of DNMT3B at 
pericentromeric satellites in ESCs; reduced global level of H3K9me3 results in loss of 
methylation at major satellites but not in other compartments, showing that H3K9me3 plays a 
role in maintaining methylation at major satellites in ESCs (Lehnertz et al. 2003). 
Genome-wide analysis shows that incorporation of the histone variant H2A.Z is anti-
correlated with presence of 5mC in human cells (J. R. Edwards et al. 2010). In fish, the 
antagonistic relationship between H2A.Z and DNA methylation was shown to be very strong at 
promoters and coding sequences (Zemach et al. 2010). Interestingly, H2A.Z was shown to 
preferentially occupy the promoter of developmental genes known to be under control of 
unmethylated promoters (Tanay et al. 2007; Creyghton et al. 2008; J. R. Edwards et al. 2010). 
Although data suggest that H2A.Z might be important to protect CpG-dense promoters against 
DNA methylation, there is no genetic evidence to support this hypothesis. 
Methylation of H3K4 is antagonistic to DNA methylation (Meissner et al. 2008; J. R. 
Edwards et al. 2010). The recent finding of binding specificity of the DNMT3 family towards 
histone H3 unmethylated at lysine 4, has revealed the existence of a molecular mechanism which 
explains the anti-correlation seen between H3K4me and DNA methylation (Meissner et al. 2008; 
J. R. Edwards et al. 2010). The PHD-like motif of both DNMT3A and DNMT3L directly 
interacts with the N-terminal tail of histone H3 (Ooi et al. 2007; Otani et al. 2009). This finding 
suggests that the presence of a nucleosomal structure is required for the methylation of the 
underlying DNA sequence. Importantly, DNMT3A and DNMT3L nucleosome targeting is 
regulated by the methylation of lysine 4, as the binding is abolished when H3K4 is mono-, di-, or 
tri-methylated (Ooi et al. 2007; Otani et al. 2009). Furthermore, the inhibition of DNMT3L 
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recruitment by H3K4me3 was confirmed in vivo by showing that DNMT3L is only associated 
with mono-nucleosomes devoid of methylation at H3K4 (Ooi et al. 2007). Crystallographic 
analysis of DNMT3L bound to the H3 tail revealed that introduction of a bulky tryptophan side 
chain into the H3 binding site of DNMT3L (I107W) or disruption of interaction between the 
aspartic acid side chain with the amino group of H3 lysine 4 (D90A) eliminates the interaction of 
the H3 tail with DNMT3L (Ooi et al. 2007). 
 The vertebrate specific histone variant macroH2A1 has a complicated relationship with 
DNA methylation: Its sub-nuclear localization is dependent on genomic methylation in ESCs 
(Damelin & Bestor 2007). In contrast, its deletion has no effects on DNA methylation 
(unpublished data). MacroH2A1 is dispensable for the silencing of methylated promoters as 
evidenced by the mild phenotype produced by its deletion in mice (Boulard et al. 2010). This 
indicates that genomic methylation plays a mysterious role for the localization of macroH2A1 
independent of its function in silencing and development. 
Global loss of genomic methylation does not influence global levels of common histone 
modifications; however genome wide distribution of histone modification has not been 
investigated in hypomethylated cells.  
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FIGURE 1C. Structure and regulation of DNMT1. Domains of DNMT1 (top).  
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N terminal regulatory domain contains nuclear localization sequence (NLS), replication focus 
targeting sequence (RFTS), CXXC domain that recognizes unmetylated DNA, and tandem 
Bromo-Adjacent-Homology (BAH) domains. N terminus is connected to the catalytic C-terminal 
domain via seven alternating lysine and glycine residues, the (GK) repeats. Letters below the 
domain diagram indicate the position of N-terminal truncations in the crystal structures shown in 
a-d. a, Superposition of active DNMT1 and M. HhaI (bacterial methyltransferase). b, 
Superposition of DNMT1 in autoinhibited state with unmethylated DNA (blue) with DNMT1 in 
active state with hemimethylated DNA (pink). Autoinhibitory BAH1-CXXC linker is depicted in 
electrostatic potential view.c. DNMT1 molecule is connected by several linkers and loops. Note 
that the (GK) repeats are not resolved in the structure and depicted with dashes.d. Almost full-








FIGURE 1D. The (GK) repeats in DNMT1. a., Alignment of the (GK) repeats of DNMT1 
homologs from mammals, insects and plants. b., At least four out of seven lysines within the 
(GK) repeats are acetylated. c.,  The (GK) repeats resembles N-terminal tails of histones, which 





I.4. Role and regulation of DNMT1 
a. DNMT1’s discovery and genetic studies 
DNMT1 was the first eukaryotic DNA methyltransferase to be purified and cloned 
(Bestor et al. 1988). This protein is 1620 amino acids long, with a 1100-amino acid N-terminal 
domain, a 500-amino acid C-terminal domain containing the catalytic site, and between them, a 
region of alternating glycine and lysine (GK) residues (Bestor et al. 1988) (Figure 1C).  
Two forms of DNMT1 are known: somatic and oocytic; the latter is lacking the first 118 
amino acids at the N-terminus, which allows it to be more stable and degradation-resistant (Ding 
& Chaillet 2002). A number of genetic mutations in Dnmt1 have been generated (summarized in 
Table 1). The first targeted mutation of Dnmt1 in mice, which resulted in a hypomorphic allele 
(Dnmt1
n/n
) with 5-10% residual activity, demonstrated global loss of methylation, demethylation 
of IAPs and embryonic lethality before mid-gestation (E. Li et al. 1992; Walsh et al. 1998). 
Subsequently, two null alleles were produced by disruption of the RFTS domain (Dnmt1
s/s
) (E. 
Li, Beard & Jaenisch 1993), and deletion of conserved PC and ENV motifs in the catalytic 
domain (Dnmt1
c/c
) (Lei et al. 1996). Both null mutations resulted in global demethylation more 
severe than that observed for the Dnmt1
n/n
 allele as well as developmental arrest prior to the 8-
somite embryonic stage and loss of imprinting (E. Li, Beard & Jaenisch 1993; Lei et al. 1996). 
The consequence of DNMT1 overexpression was studied by introduction of a BAC carrying the 
full Dnmt1 gene into wild type ES cells, which resulted in DNMT1 levels increased to 4 times 
that of wild type and 150% increase in methylation activity (Biniszkiewicz et al. 2002). Injection 
of DNMT1-overexpressing ES cells into diploid and tetraploid embryos resulted in mid-gestation 
lethality, and, while global methylation levels were normal, both alleles of H19 DMR were 
methylated (Biniszkiewicz et al. 2002).  
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Meanwhile, null mutation of the oocyte form of DNMT1 was created by deletion of exon 
1o. (Howell et al. 2001). This resulted in normal viability of homozygous mutants, but 
heterozygous offspring of mutant females died in late gestation and displayed loss of allele-
specific expression and methylation at certain imprinted genes suggesting that DNMT1o is 
required for maintenance of imprints that otherwise would be lost during the fourth embryonic S 
phase in the 8-cell embryo (Howell et al. 2001). Deletion of exon 1s in mice, forcing the 
production of the oocytic form of DNMT1 in all cells demonstrated that DNMT1o can 
functionally substitute for somatic DNMT1 and maintain normal methylation at all sequences, 
even though DNMT1o accumulates over time to protein levels 5 times that of wild type and 
exhibits 350% greater methylation activity (Ding & Chaillet 2002). This mutation thus 
demonstrated the intrinsic stability of DNMT1o that allows for its prolonged storage in oocytic 
cytoplasm, where it remains until being trafficked into the nuclei of the 8-cell embryo to 
maintain methylation at imprinted genes (Ding & Chaillet 2002; Howell et al. 2001).  
 
 
TABLE 1. List of genetic studies of Dnmt1.  
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Biochemical studies have demonstrated that DNMT1 has a 5- to 30-fold preference for 
hemimethylated over unmethylated DNA (Yoder et al. 1997) (Bestor 1992; S. Pradhan et al. 
1999), though its activity on unmethylated DNA is greater than that seen for DNMT3A and 
DNMT3B (Okano et al. 1998) (Figure 1B). Still, the primary in vivo function of DNMT1 is 
thought to be the precise replication of genomic DNA methylation patterns to maintain them 
after each cell division. It appears that regulatory domains within the N-terminal section of the 
protein are responsible for limiting DNMT1 function in vivo to solely maintenance methylation, 
as the cleavage of the N-terminal section from the C-terminal catalytic domain causes increased 
de novo methylation activity on unmethylated substrate (Bestor 1992; Bestor and Ingram, 1983, 
Gruenbaum, 1982).  
The regulatory domains within DNMT1’s N-terminus include (Figure 1C) the replication 
foci targeting sequence (RFTS, also known as RFD), nuclear localization signal, a zinc finger 
CXXC (Cys-X-X-Cys) domain, CXXC-BAH1 autoinhibitory linker and tandem BAH domains. 
Structurally, the catalytic C-terminal domain exhibits a high degree of similarity to the bacterial 
restriction methyltransferases (Bestor et al. 1988; Bestor 1992), which do not posses any 
analogue of DNMT1’s N-terminal regulatory structures (Figure 1C).  
Within the past several years, different laboratories were successful in solving crystal 
structures of mouse and human DNMT1 molecules in active (with hemimethylated DNA) (Song 
et al. 2012), inhibited (with unmethylated DNA) (Song et al. 2011), and free states (no DNA) 
(Takeshita et al. 2011) (Z.-M. Zhang et al. 2015).  Such a diverse database of DNMT1 structures 
offers a unique opportunity to study the molecular mechanisms of maintenance DNA 
methylation, with special emphasis on the role of N-terminal regulatory domains.  In the 
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following sections, the various regulatory domains of the DNMT1 molecule are considered with 
respect to their structures and what is consequently known about their function.  
 
b. Structural insights into DNMT1 regulation  
i. RFTS and targeting to sites of DNA replication 
The RFTS, or replication foci targeting sequence (also knows at RFD or replication focus 
domain), is essential for the localization of DNMT1 to replication foci during S phase of the cell 
cycle (Leonhardt et al. 1992). This localization occurs through the interaction of RFTS with 
UHRF1, an E3 ubiquitin ligase (Bostick et al. 2007) (Sharif et al. 2007) (discussed further in 
section I.c.I). The single most important signal for the recruitment of DNMT1 to replication foci 
is hemimethylated DNA: this conclusion derives from several studies showing that catalytic 
mutation in the methyltransferase domain renders DNMT1 inactive and causes its 
mislocalization (Damelin & Bestor 2007; Takebayashi et al. 2007).  
The crystal structure of hDNMT1 in the free state, resolved at 2.62 A, shows that the 
RFTS domain exercises an inhibitory role through its direct binding at the catalytic site (Z.-M. 
Zhang et al. 2015) (Figure 1C(d)). It is also possible that RFTS binding to UHRF1 at replication 
foci induces allosteric changes in DNMT1 shifting its conformation from inhibited to the active 
form.  
The only pathogenic mutations identified in Dnmt1 to date are all located within the 
RFTS domain (Figure 1E), and contribute to the development of the autosomal dominant 
DNMT1-complex disorder, which is characterized by narcolepsy, hearing loss, mild to severe 
neuropathy and cognitive decline (Baets et al. 2015). Previously, this disorder was separated into 




FIGURE 1E. Pathogenic mutations of DNMT1. The RFTS domain of DNMT1 is subject to 
different dominant mutations in a variable adult onset cerebellar ataxia, deafness, dementia, and 
narcolepsy syndrome (autosomal dominant DNMT1-complex disorder).   
 
 
cerebellar ataxia, deafness, narcolepsy (ADCA-DN) (Sun et al. 2014; Klein et al. 2011; Klein et 
al. 2013). However, after examination of a large cohort of patients and identification of high 
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phenotypic overlap of HSAN1E and ADCA-DN, Baets et al., 2015 suggested to unite these two 
conditions under the name of “DNMT1-complex disorder”. As yet, the following mutations in 
the RFTS domain have been identified in patients with DNMT1-complex disorder: C353F, 
T481P, D490E, P491L, P491Y, P491R, Y495C, Y495H, K505del, Y524D, I531N, H553R, 
A554V, C580R, G589A, V590F ((Baets et al. 2015; Klein et al. 2013; Klein et al. 2011; 
Moghadam et al. 2014)). Methylation analysis of patients with the most common Y495C 
mutation displayed a decrease in the global methylation level of only 0.3-3%, with most of the 
demethylation occurring in intergenic regions (Sun et al. 2014), implying that changes in DNA 
methylation do not, in fact, contribute to the pathogenesis of this disease.  Interestingly, it is 
known that DNMT1 continues to be expressed in post-mitotic neurons (Goto et al. 1994; Trasler 
et al. 1996; Inano et al. 2000), which do not need methylation maintenance. Accordingly, it can 
most likely be inferred that a neuron-specific effect of DNMT1 contributes to DNMT1-compex 
disorder. Baets at el., 2015 also found that mutant DNMT1 proteins when overexpressed in 
HEK293 cells mislocalize and aggregate in the cytoplasm. This observation potentially provides 
a link between DNMT1-complex disorder and the aggregative proteinopathies seen in many 
neurodegenerative disorders (Ross & Poirier 2004; Ciryam et al. 2013). However, the role of 
these DNMT1 mutations has not been studied in vivo in the brain; the creation of a mouse model 
would be an essential tool to understanding the pathogenic mechanisms behind DNMT1 mutants 
but has not yet been undertaken.  
Interestingly, one of the ubiquitination sites within DNMT1, lysine 586 (Lecona et al. 
2016), is located within one cluster of DNMT1-complex disorder-associated mutations (A554V, 
C580R, G589A and V590F).  
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ii. Autoinhibitory role of CXXC domain 
In other DNA-binding proteins, CXXC domains previously have been reported to 
specifically bind unmethylated CpG dinucleotides (Allen et al. 2006; Birke et al. 2002; Lee et al. 
2001; M. Pradhan et al. 2008). For example, the CXXC-containing FBXL10 protein binds to 
unmethylated CpG islands and protects them from acquiring DNA methylation (Boulard et al. 
2015). The fact that the maintenance DNA methyltransferase DNMT1 contains a domain that 
recognizes unmethylated rather than hemimethylated DNA (M. Pradhan et al. 2008) is thus 
rather surprising. Nonetheless, the crystal structure of mouse and human DNMT1 with 
unmethylated DNA revealed that the CXXC domain in DNMT1 actually participates in 
autoinhibitory mechanism in the presence of unmethylated DNA (Song et al. 2011)  
(Figure 1-C (b)). First, CXXC anchors unmethylated DNA in such a way that it keeps it at a 
distance from the active site of DNMT1. Second, the CXXC-BAH1 autoinhibitory linker, which 
is composed of negatively charged residues that repel DNA, is positioned between the active site 
and the unmethylated DNA. As such, unmethylated CpG site are prevented from entering the 
active site of DNMT1. Mutagenesis studies have demonstrated that the CXXC domain 
contributes 6- to 7-fold preference for hemimethylated over unmethylated DNA (Song et al. 
2011), whereas DNMT1 itself has up to 30-fold preference for the hemimethylated species in 
vitro (Yoder et al. 1997). It thus cannot be excluded that other mechanisms might exist to 
account for any remaining difference.  
 
iii. BAH domains 
The first BAH (Bromo-Adjacent-Homology) domain was identified in the chicken 
protein Polybromo, where, as its name implies, it is situated next to several Bromo domains 
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(Yang & R.-M. Xu 2013). BAH domains are mostly found in chromatin factors, such as S. 
cerevisiae Risc1/2, D. melanogaster Ash1, and S. pombe Orc1 (Origin of Replication Complex 
1). The precise function of BAH domains remained enigmatic for some time until their further 
characterization in two proteins, ORC1 and Sir3, categorized them as histone-recognizing 
modules (Kuo et al. 2012; Armache et al. 2011).  Mutational analysis and crystal structures have 
showed that the BAH domain of ORC1 specifically recognizes dimethylated lysine 20 of histone 
H4 (Kuo et al. 2012), while Sir3’s BAH domain binds nucleosome possessing unmodified lysine 
16 of histone H4 and unmodified lysine 79 of histone H3 (Armache et al. 2011).  
DNMT1 contains two tandem BAH domains that have a dumbbell-shaped configuration 
in the crystal structure (Song et al. 2011; Song et al. 2012; Takeshita et al. 2011); their potential 
function in the process of DNA methylation is unknown (Figure 1C). Structural and sequence 
homology with the ORC1 BAH domain suggests that DNMT1’s BAH1 domain could be a 
methyllysine-binding domain (Yang & R.-M. Xu 2013). Both of DNMT1’s BAH domains are 
positioned on the surface remote from the bound DNA, although BAH1 connects to the CXXC 
via the autoinhibitory linker (Song et al. 2011), and BAH2 contains a long protruding loop that 
makes contacts with both the TRD and with the phosphate backbone of the bound DNA in the 
active structure (Song et al. 2012).  
There is disagreement in the literature on the question of DNMT1 binding to 
nucleosomes (Jeong et al. 2009; Gowher, Stockdale, et al. 2005). Biochemical experiments seem 
to strongly support the conclusion that in contrast to DNMT3A and DNMT3B, DNMT1 does not 
make stable association with chromatin (Jeong et al. 2009). Given the dynamics of maintenance 
methylation, such that DNMT1 must be constantly moving onto the next target hemimethylated 
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site, any stable interaction with chromatin indeed seems implausible, though a transient 
interaction with nucleosomes cannot be excluded.  
 
iv. (GK) repeats 
The (GK) repeats motif is constituted by 13 alternating glycine and lysine residues that 
link the regulatory N-terminus to the catalytic C-terminal domain (Figure 1C). Though little 
studied, the (GK) repeats stand out as a potentially important functional sequence in DNMT1 for 
several reasons. First, they are conserved among eukaryotic DNMT1 homologs (Figure 1D (a)). 
Second, four out of seven lysines within the (GK) repeats can be acetylated (Kim et al. 2006; 
Choudhary et al. 2009), indicating a possible regulatory function (Figure 1D (b)). Third, the 
(GK) repeats significantly resemble the GK dipeptides in the N-terminal tails of core histones 
H2A, H4 and noncanonical histone variant H2A.Z (Figure 1D (c)). Acetylation of these GK 
dipeptides within histones is well known to reduce electrostatic interaction with DNA, thus 
relaxing chromatin. 
 
v. Methyltransferase domain and mechanism of methylation 
The methyltransferase domain of DNMT1 consists of two subdomains called the catalytic 
core and the TRD (target recognition domain), adopting a class I methyltransferase fold (Song et 
al. 2011). Comparison of mouse DNMT1 with M.HhaI (Haemophilus haemolyticus 
methyltransferase) (Figure 1C (a)) demonstrates that the overall fold of the catalytic domain is 
similar between mammalian and bacterial enzymes, but several differences stand out: 1) five (I, 
VI, VIII, IX, X) out of six conserved sequence motifs adopt a similar conformation, while motif 
IV containing the catalytic loop and catalytic cysteine adopts different conformations; 2) the 
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DNA helix in M.HhaI can only be positioned within a cleft formed by the catalytic core and the 
TRD, while DNA can shift positions within mDNMT1, entering the cleft in the active structure 
and being laterally displaced from the catalytic site by the CXXC domain in the inhibited 
structure; 3) the TRD subdomains have little sequence similarity while both contain an 8-amino 
acid DNA recognition loop, a second 8-amino acid loop in M.HhaI is replaced by a 73-residue 
loop in mDNMT1 (Song et al. 2011; Song et al. 2012).  
The formation of the active DNMT1-DNA complex involves invasion of the DNA major 
groove by two TRD loops and the minor groove by the catalytic loop (Song et al. 2012). The 
DNA duplex of hemimethylated DNA is embedded in the catalytic cleft of DNMT1 with the 
target cytosine looped out of the helix and inserted into the catalytic pocket of the 
methyltransferase domain, where it forms a covalent bond with the reactive cysteine (Cys 1229) 
(Song et al. 2012). The target cytosine is surrounded by residues that are completely conserved 
between mammalian and bacterial enzymes and is in proximity to the S-adenosyl homocysteine 
(AdoHcy) (Song et al. 2012).  
Interestingly, the methylated cytosine on the parental strand is accommodated within a 
shallow concave and hydrophobic surface within the TRD domain, and in vitro mutation of 
tryptophan 1512 of the TRD, which is involved in base-stacking with the 5-methylcytosine 
yields a catalytically dead DNMT1 (Song et al. 2012). Comparison of active (Song et al. 2012) 
and autoinhibited (Song et al. 2011) DNMT1-DNA complexes shows that the largest 
conformational change takes place within the catalytic loop of the methyltransferase domain, 




c. Regulation of DNMT1 by other proteins 
i. UHRF1 is essential for maintenance DNA methylation 
UHRF1 (ubiquitin-like, containing PHD and RING finger domain 1), formerly known as 
NP95 (nuclear protein 95), is a homolog of the plant protein VIM1/ORTH2, required for 
maintenance of CG methylation at centromeric repeat sequences in Arabidopsis ( Johnson 2007, 
Woo 2007).  Null mutation of Uhrf1 phenocopies null mutation of Dnmt1 resulting in almost 
complete loss of genomic methylation and embryonic arrest in early gestation (Bostick et al. 
2007; Sharif et al. 2007). UHRF1 binds with high affinity to hemimethylated CpG sites through 
its SET and RING finger associated (SRA) domain (Bostick et al. 2007; Sharif et al. 2007) via a 
base-flipping mechanism (Arita et al. 2008; Avvakumov et al. 2008; Hashimoto et al. 2008), and 
recruits DNMT1 to sites of newly replicated hemimethylated DNA at replication foci during S 
phase (Bostick et al. 2007; Sharif et al. 2007). Interaction of UHRF1 and DNMT1 is mediated 
via the latter’s RFTS domain, which is important for proper localization of DNMT1 during S 
phase (Leonhardt et al. 1992; Garvilles et al. 2015).  
UHRF1 also contains tandem tudor domains that recognize H3K9me3 and a PHD finger 
that assists the tudor domains and also recognizes unmodified H3R2 (Rothbart et al. 2012). In 
vitro and cell culture studies have demonstrated that interaction of UHRF1 with H3K9me3 might 
be necessary for DNA methylation (Rothbart et al. 2012; Liu et al. 2013) however, mutation of 
Uhrf1 in mice making the protein incapable of binding histones showed that loss of this 
interaction leads to only 10% loss of global DNA methylation, suggesting that maintenance 
methylation is mostly independent of H3K9me3 (Zhao et al. 2016).  
Direct interaction of DNMT1 and UHRF1 has been demonstrated by several groups 
(Felle et al. 2011; Du et al. 2010; Garvilles et al. 2015), however, recently it has been proposed 
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that ubiquitination of H3K23 in Xenopus (Nishiyama et al. 2013) and H3K18 in mammals (Qin 
et al. 2015) might act as an intermediate for their functional interaction. This model suggests that 
RING domains of UHRF1 ubiquitinates histone H3, which is subsequently recognized by the 
RFTS domain of DNMT1 (Nishiyama et al. 2013; Qin et al. 2015). It is presently not known if 
UHRF1 has the ability to ubiquitinate DNMT1, though two ubiquitination sites in the enzyme 
recently have been identified: lysines 586 in the RFTS domain and lysine 997 in the BAH2 
domain (Lecona et al. 2016).  
UHRF1 is the only characterized factor up to date that is known to be required for 
maintenance DNA methylation in addition to DNMT1.  
 
ii. Acetylation-ubiquitination regulation by USP7 and TIP60 
A recently proposed model on the control of DNMT1 by an acetylation-ubiquitination 
coupled mechanism suggests a link between DNMT1 biosynthesis/degradation and the cell 
cycle; the molecular mechanism involves interactions with deubiquitinase USP7 and 
acetyltransferase TIP60 (Du et al. 2010).  
Ubiquitin-specific protease 7 (USP7; also known as Herpes-associated ubiquitin-specific 
protease or HAUSP) is important for regulation of p53 and MCM2 stability (M. Li et al. 2002; 
Hu et al. 2006; Sheng et al. 2006). It has been reported that during S phase USP7 binds to 
unacetylated (GK) repeats of DNMT1 and stabilizes the enzyme by deubiquitination (Cheng et 
al. 2015). Later in S phase and during early G2 phase, TIP60 acetylates the (GK) repeats, which 
subsequently leads to the dissociation of DNMT1/USP7 complex (Du et al. 2010), ubiquitination 
of DNMT1 at lysine 586 (RFTS domain) and lysine 997 (BAH2 domain) (Lecona et al. 2016), 
and proteasomal degradation of DNMT1.  
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This model was formulated based on in vitro biochemical studies, while genetic analysis 
is complicated by the fact that Usp7 mutation leads to DNA replication defects (Lecona et al. 
2016) and cell lethality via p53 misregulation (M. Li et al. 2002). We further test the proposed 
model in Chapter 3.  
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I.5. Outline of Thesis 
 Having reviewed the relevant body of literature underlying this work, we now turn our 
attention to reporting the new findings we have generated concerning regulatory domains of the 
maintenance methyltransferase DNMT1. 
Chapter 2 describes how the previously unknown function of DNMT1's (GK) repeats was 
elucidated using reverse genetics. It also provides evidence establishing a novel in vivo role of 
DNMT1 in de novo methylation of paternally imprinted DMRs. In Chapter 3, we round out our 
investigation of the (GK) repeats by challenging the preliminary model put forward in prior 
literature that implicates this motif in DNMT1's interaction with USP7 and regulation throughout 
the cell cycle. Chapter 4 explores the function of DNMT1's BAH domains as protein-binding 
modules and demonstrates that they are required for targeting of the enzyme to replication foci 
during S phase. Finally, with Chapter 5, we take the opportunity to consider more broadly the 
significance of these findings as well as future perspectives for the field of epigenetics. 
In the end, this thesis aims to overturn some of the basic assumptions that have long held 
sway in the study of the molecular mechanisms of DNA methylation and yield a more nuanced 
understanding of the complex machinery that has evolved for this purpose. 
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CHAPTER II. ACETYLATED (GK) REPEATS PREVENT DNMT1 FROM CARRYING 
OUT DE NOVO METHYLATION AT PATERNALLY IMPRINTED GENES IN 
EMBRYONIC STEM CELLS 
 
II.1. Rationale and Summary 
Mammalian DNMT1 has a large N-terminus with several distinct domains that regulate 
the enzyme’s targeting (RFTS), nuclear localization, and binding to DNA (CXXC) (Figure 1-C). 
However, several domains within DNMT1 have unknown function, among which is a short 
motif of (GK) repeats. The (GK) repeats are composed of 13 alternating glycine and lysine 
residues and link the regulatory N-terminus to the catalytic C-terminus. The (GK) repeats stood 
out as a potential functional sequence in DNMT1 for several reasons. First, they are conserved 
among eukaryotic DNMT1 homologs (Figure 1D(a)). Second, four out of seven lysines within 
the (GK) repeats can be acetylated (Kim et al. 2006; Choudhary et al. 2009) which indicates a 
possible regulatory function (Figure 1D(b)). Third, the (GK) repeats closely resemble the GK 
dipeptides in the N-terminal tails of histones H2A, H4 and H2A.Z (Figure 1D(c)). Acetylation of 
these GK dipeptides within histones is well known to reduce electrostatic interaction with DNA, 
which relaxes chromatin. Hence, I hypothesized that enzymatic activity of DNMT1 could be 
modulated through neutralization of the positive charge of the (GK) repeats.  
This chapter describes the phenotype and functional consequences of the first attempted 
genetic mutagenesis of the (GK) repeats in mouse ES cells. Methylation analysis of cells 
expressing DNMT1 with fully substituted (GK) repeats identifies the function of this motif in 
methylation of paternally imprinted genes. The data presented here revealed that mutation of the 
(GK) repeats motif confers de novo methyltransferase activity to DNMT1.  
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II. 2. Materials and Methods 
a. Cell lines and cell culture 
Mouse ES cells were cultured on gelatin following standard techniques. Stable ES cell lines were 
generated by nucleofection of Dnmt1-null ES cells (Lei et al. 1996) with MT80 minigene (Figure 
2A) and pGKPuro plasmid for Puromycin resistance. MT80 minigene, carrying 12kb of 5’ 
Dnmt1 genomic sequence with endogenous promoter and 5.5kb of Dnmt1 cDNA (Tucker, 
Talbot, et al. 1996; Damelin & Bestor 2007), was modified by the addition of the N-terminal 
Flag-HA tag after the translation start site. Point mutations were produced using QuikChange 
Site-Directed Mutagenesis kit (Agilent). Individual clones were selected with Puromycin for 10-
14 days and picked into 96-well plates.  Clones were genotyped using primers specific to the 
Flag-HA tag . Positive clones were propagated and levels of DNMT1 expression were tested by 





FIGURE 2A. Dnmt1 minigene system used for genetic rescue experiments. Construct contains 
12 kb of genomic DNA with endogenous Dnmt1 promoter. Minigene was modified by the 
addition of HA and FLAG tags after the translation start site. Dnmt1 point mutations were 




Whole cell extracts were prepared by lysis in RIPA buffer (150mM NaCl, 1% NP-40, 0.5% 
Deoxycholic acid, 0.1% SDS, 50mM Tris pH 7.5) and briefly sonicated to disrupt genomic 
DNA, then heated to 100° in SDS and loaded onto SDS-PAGE gels. Proteins were transferred to 
nitrocellulose membrane and blocked in 5% milk, 0.1% Tween20, PBS for 1 hour at room 
temperature. Blots were incubated at 4
0
C overnight with primary antibodies in 10% FBS, 0.1% 
Tween20. Blots were washed with PBST, after incubation with DNMT1 antibody blots were 
washed briefly with PBST and PBS. Antibodies used: rabbit polyclonal to DNMT1 (Cell 
Signaling Technology, 5032 (D63A6) 1:2,500 dilution), rabbit polyclonal to HA tag (Abcam, 
ab9110, 1:5000), mouse monoclonal to alpha-tubulin (Abcam, ab7291, 1:10,000).  
 
c. Methylation analysis 
Genomic DNA was digested for two rounds with methylation-sensitive enzyme HpaII 
(recognition sequence CCGG), its isoschizomer MspI as a control, or McrBC that cuts DNA 
between two methylated sites. DNA was quantified and ran on 0.8% agarose gel, and stained 
with ethidium bromide.  
 
d. Southern blots 
Southern blot analysis was performed with IAP probe generated by PCR. Primers (matching to 
LTR+GAG) used for probe amplification: probe_IAP_F (GGTAAACAAATAATCTGCGC); 
probe_IAP_R (CTGGTAATGGGCTGCTTCTTCC). Probes for minor and major satellites were 
prepared by EcoRI digestion from plasmids (gift of Mathieu Boulard). Agarose gels were 
transferred to a Nytran SPC membrane (GE Healthcare) overnight in 10X SSPE buffer. After 
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crosslinking, membrane was prehybridized with 6X SSC, 5X Denhardts, 1% SDS, 10% Dextran 
Sulfate for 1hour at 45° and incubated overnight with IAP probe at 45°. Membranes were 
washed once with 2X SSC, 0.5% SDS; 2X with 1X SSC, 0.5% SDS, and 1X with 0.2X SSC, 
0.5% SDS.  
 
e. Bisulfite sequencing 
Genomic DNA isolated from ES cells was bisulfite converted using the EZ DNA Methylation-
Gold kit. All imprinted genes were amplified with two rounds of nested or semi-nested PCR 
using the primer pairs listed in Table 2. The PCR product resulting from the second round of 
PCR was sequenced using Sanger sequencing.  
Primer name Forward primer Reverse primer 
H19_BS1 GAGTATTTAGGAGGTATAAGAATT ATCAAAAACTAACATAAACCCCT 




Kcnq1ot1_BS1 TATAAGGAAGGTTAAGAATTTATTGTAATTATTG AATTTCTTCTCTAAATCAACACRACACAAA 




IG-DMR_BS1 AGATGTGTTGTGGATTTAGGTTGTAG CTAAACTACAATCTATATAATCACAACAC 




Rasgrf1_1 GAGAGTATGTAAAGTTAGAGTTGTGTTG  ATAATACAACAACAACAATAACAATC  




Peg1_1 GATTTGGGATATAAAAGGTTAATGAG TCATTAAAAACACAAACCTCCTTTAC 




Peg3_1 TTTTTAGATTTTGTTTGGGGGTTTTTAATA AATCCCTATCACCTAAATAACATCCCTACA 
Peg3_2 TTGATAATAGTAGTTTGATTGGTAGGGTGT ATCTACAACCTTATCAATTACCCTTAAAAA 
      
Snrpn_BS1 TATGTAATATGATATAGTTTAGAAATTAG AATAAACCCAAATCTAAAATATTTTAATC 
Snrpn_BS2 AATTTGTGTGATGTTTGTAATTATTTGG ATAAAATACACTTTCACTACTAAAATCC 
 






RNA was extracted from ES cells using Trizol and chloroform, and subsequently treated with 
TurboDNAse. After precipitation with sodium acetate and ethanol, 1ug of RNA was used for 
cDNA synthesis using Superscript IV.  cDNA was diluted 1/15 and used for RT-qPCR. We used 
PowerUp SYBR Green PCR Master Mix (catalog no. A25742; Applied Biosystems). Primers for 
H19 and b-actin were a kind gift of Mathieu Boulard. 
g. Statistical analysis 
Peak heights for methylated and unmethylated alleles at each CpG site were quantified using 





a. GR substitution of the (GK) repeats does not alter DNMT1 stability 
To investigate the function of the (GK) repeats, we made seven substitutions of all lysine 
residues within the repeats to arginines (Figure 2B). Such substitution preserved the positive 
charge of the (GK) repeats while rendering them unacetylatable. Expression constructs that 
produced wild-type GK or GK→GR DNMT1 were transfected into Dnmt1-null ES cells and 
stable clones were established as described in the Methods. Expression was driven by a 12kb 
segment of DNA 5’ to the Dnmt1 gene, which contains the endogenous Dnmt1 promoter and 
other regulatory sequences necessary for expression of DNMT1 at wild-type levels(Tucker, 
Talbot, et al. 1996; Damelin & Bestor 2007).  As shown in Figure 2B(b), GK and GR proteins 
were expressed at levels similar to that of endogenous DNMT1 in the wild type, suggesting that 
the GK→GR substitution results in a stable DNMT1 protein.  
 
b. GR DNMT1 rescues methylation globally and at repetitive sequences 
The methylation status of GR cells was determined by digestion of genomic DNA with 
the methyl-sensitive restriction enzyme HpaII. Figure 2B(c) shows that similarly to GK protein, 
GR DNMT1 rescues global methylation levels to wild-type levels. Further Southern blot analysis 
revealed that GR DNMT1 is able to normally methylate IAP retrotransposons and minor satellite 
repeat sequences (Figure 2B(c)) indicating that mutation of the (GK) motif does not compromise 
the maintenance activity of DNMT1. Accordingly, we can conclude that acetylation of the (GK) 
repeats is not involved in the regulation of the methyltransferase activity of DNMT1 or its 
targeting to replication foci.  
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c. GR DNMT1 produces ectopic gain of methylation at paternally imprinted genes 
While restrotransposons and repetitive elements constitute the majority of methylated 
DNA, another essential compartment where methylation plays an important regulatory role are 
imprinted genes. Imprinted genes are a set of genes that are monoallelically expressed in a 
parent-of-origin dependent manner. The choice of the expressed allele in the embryo is under the 
control of sex-specific methylation patterns that are established in the parental germline 
(Bourc'his & Bestor 2006). 
It has been shown previously that reintroduction of Dnmt1 after its ablation or transient 
inhibition in ES cells fails to restore genomic imprints both at paternal and maternal DMRs 
(Tucker, Beard, et al. 1996; McGraw et al. 2015). In fact, imprinting information can be restored 
only upon germline transmission (Tucker, Beard, et al. 1996) suggesting either the existence of a 
germline factor necessary for imprint establishment or the presence of an inhibitory factor in ES 
cells that must be absent in the germline.  
The methylation status of all three paternally imprinted DMRs H19, Dlk1/Gtl2 and 
Rasgrf1 was examined using bisulfite sequencing of genomic DNA derived from GK or GR 
cells. Analysis revealed that all three paternal imprints exhibited de novo methylation in GR cells 
(Figures 2C, 2D, 2E), which was statistically significant when compared to wild type GK (all p-
values are equal or below 0.01). On average GR cells exhibited a 30% gain of methylation 
(Figures 2C(b); 2D(b); 2E(b)). H19 result was validated by subcloning and sequencing of 
individual clones (Figure 2C(c)). 
Importantly, reintroduction of wild-type GK DNMT1 does not catalyze de novo 
methylation at paternal imprints. Therefore, ectopic methylation at paternally imprinted genes 
originates from the mutation of the (GK) motif. This result was surprising as it was thought that 
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DNMT1 specialized in maintenance methylation. Our data reveals that mutation that prevents 
acetylation of the (GK) repeats confers a de novo methylation activity unto DNMT1. 
Bisulfite analysis was done on two independent wild type GK and two GR lines, and 
quantified data for both clones for all three genes is statistically significant (Figures 2C(b); 
2D(b); 2E(b)). This experiment does not discriminate between paternal and maternal alleles, 
therefore this gain of methylation could be restricted to one allele or randomly distributed 
between both alleles.  
The same experiment was conducted on wild-type and Dnmt1-null ES cells as an 
important control to show that wild type cells exhibit normal monoallelic methylation, while 
cells lacking Dnmt1 show a complete loss of methylation at imprinted loci (Figures 2C(a); 2D(a); 
2E(a)).   
 
d. Expression of GR DNMT1 has no effect on methylation at maternally imprinted genes. 
Using bisulfite analysis methylation levels were determined at the following maternally 
imprinted DMRs: Igf2r, Kcnq1ot1, Snrpn, Peg3 and Peg1 (Figures 2F; 2G; 2H; 2I; 2J). In 
contrast to paternally imprinted genes, at each of the maternal imprints examined there was no 
gain of ectopic methylation in GR cells. Bisulfite analysis was done on two independent GK and 
two GR lines producing the same result. Control experiments on wild-type and Dnmt1-null ES 
cells were carried out to confirm the presence of expected patterns of methylation (Figures 2F; 
2G; 2H; 2I; 2J).  
The striking difference in the effects on paternal and maternal imprints in GR cells points 
to a previously unknown mechanism by which DNMT1 is capable of recognizing and de novo 
methylating specifically paternal DMRs.  
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e. Gain of methylation at paternally imprinted genes results in transcriptional changes  
To investigate the functional consequences of the observed gain of methylation at 
paternal imprints, RT-qPCR was conducted on RNA from GK and GR cells with primers for 
H19 and Igf2. RNA from wild-type and Dnmt1-null ES cells was used as a control to show that 
when H19 DMR is demethylated, the expression of H19 gene increases, while the expression of 
Igf2 drops. The role of DNA methylation in regulation of imprinted genes has been well 
characterized (Reik et al. 1987; Sapienza et al. 1987; Swain et al. 1987; Wutz et al. 1997; 
Thorvaldsen et al. 1998). We hypothesized that expression of paternally imprinted genes in GR 
cells will be altered in comparison to Dnmt1-null and GK cells. RT-qPCR analysis revealed that 
expression of H19 is significantly decreased in GR cells (Figure 2K), and is lower than in wild-




FIGURE 2B. Substitution of lysines by arginines within the (GK) repeats does not affect 
maintenance methylation. a., Position of GK to GR substitution within the (GK) repeats of 
DNMT1. b., GR substitution does not effect DNMT1 stability. Stable clones expressing wild-
type levels of DNMT1 were further analyzed. c., Normal methylation of genomic DNA as 
measured by resistance to methyl-sensitive restriction enzyme HpaII; Southern blot analysis with 





FIGURE 2C. Methylation status of H19 paternally imprinted DMR. a., Sequencing traces for 
PCR products amplified from bisulfite-converted genomic DNA using nested primers for H19. 
Unmethylated molecules are represented by TG, methylated molecules are represented by CG. 
Wild type and Dnmt1
-/-
 were used as controls. GR clones exhibit de novo methylation at all CpG 
sites. b., Methylation levels across all CpG sites were quantified for two independent wild type 
GK and GR clones. p-value was calculated using Mann-Whitney test (left). Quantification of 
methylation levels at individual CpG sites (right). c., Amplified PCR products were subcloned 
into pJET and individual colonies sequenced, confirming the phenotype when sequencing bulk 





FIGURE 2D. Methylation status of Dlk1/Gtl2 paternally imprinted DMR. a., Sequencing traces 
for PCR products amplified from bisulfite-converted genomic DNA using nested primers for 
Dlk1/Gtl2. Unmethylated molecules are represented by TG, methylated molecules are 
represented by CG. Wild type and Dnmt1
-/-
 were used as controls. GR clones exhibit de novo 
methylation at all CpG sites. b., Methylation levels across all CpG sites were quantified for two 
independent wild type GK and GR clones. p-value was calculated using Mann-Whitney test 





FIGURE 2E. Methylation status of Rasgrf1 paternally imprinted DMR. a., Sequencing traces for 
PCR products amplified from bisulfite-converted genomic DNA using nested primers for 
Rasgrf1. Unmethylated molecules are represented by TG, methylated molecules are represented 
by CG. Wild type and Dnmt1
-/-
 were used as controls. GR clones exhibit de novo methylation at 
all CpG sites. b., Methylation levels across all CpG sites were quantified for two independent 
wild type GK and GR clones. p-value was calculated using Mann-Whitney test (left). 






FIGURE 2F. Methylation status of Kcnq1ot1 maternally imprinted DMR. Sequencing traces for 
PCR products amplified from bisulfite-converted genomic DNA using nested primers. 
Methylated sites are denoted by filled in blue peaks and marked by CG, unmethylated sites are 
marked by red trace and TG. Wild type and Dnmt1
-/-
 were used as controls. GR clones do not 






FIGURE 2G. Methylation status of Igf2r maternally imprinted DMR. Sequencing traces for 
PCR products amplified from bisulfite-converted genomic DNA using nested primers. 
Methylated sites are denoted by filled in blue peaks and marked by CG, unmethylated sites are 
marked by red trace and TG. Wild type and Dnmt1
-/-








FIGURE 2H. Methylation status of Snrpn maternally imprinted DMR. Sequencing traces for 
PCR products amplified from bisulfite-converted genomic DNA using nested primers. 
Methylated sites are denoted by filled in blue peaks and marked by CG, unmethylated sites are 
marked by red trace and TG. Wild type and Dnmt1
-/-








FIGURE 2I. Methylation status of Peg1 maternally imprinted DMR. Sequencing traces for PCR 
products amplified from bisulfite-converted genomic DNA using nested primers. Methylated 
sites are denoted by filled in blue peaks and marked by CG, unmethylated sites are marked by 
red trace and TG. Wild type and Dnmt1
-/-








FIGURE 2J. Methylation status of Peg3 maternally imprinted DMR. Sequencing traces for PCR 
products amplified from bisulfite-converted genomic DNA using nested primers. Methylated 
sites are denoted by filled in blue peaks and marked by CG, unmethylated sites are marked by 
red trace and TG. Wild type and Dnmt1
-/-
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FIGURE 2K. Expression of H19 is altered in GR clones. RT-qPCR was performed on biological 
triplicates. Wild type and and Dnmt1
-/-
 cDNA were used as controls. H19 is upregulated in 
Dnmt1
-/-
 due to the demethylation of both alleles. Decreased expression in GR clones 































FIGURE 2L. Model of acetylation-dependent maintenance and de novo functions of DNMT1. 
When acetylated at the (GK) repeats DNMT1 carrying out only maintenance DNA methylation, 





The data presented in this chapter demonstrate that cells expressing mutant DNMT1 with 
unacetylatable arginines substituting for the lysine of the (GK) repeats with arginines and 
thereby rendering them un-acetylatable, have an ectopic gain of methylation at paternally 
imprinted genes, while maternal imprints do not similarly acquire abnormal methylation (Table 
3). Furthermore, the observed gain of methylation has a functional effect and results in changes 
in the transcription of paternally imprinted genes, such as H19. Importantly, GR protein is stable 
and functional as evidenced by the fact that it rescues global methylation levels as well as 
methylation at IAPs and minor satellites. Based on these findings, we propose a model in which 
DNMT1 in its unacetylated state acquires a de novo methyltransferase function specifically at 
paternal DMRs. This model raises the possibility that unacetylated DNMT1 establishes de novo 
methylation at paternal imprints in prospermatogonia.  
 
a. Expression of DNMT1 in gonocytes during male imprint establishment 
Paternal imprints are established in the male germline between embryonic days E14.5 
and E16.5 (Kato et al. 2007). The paradigm in the field of DNA methylation has been that 
DNMT1 is strictly a maintenance enzyme, and accordingly it was concluded that DNMT1 is not 
expressed during stages of genome-wide remethylation. However, careful examination of the 
primary literature shows that this interpretation might not be true on all the cases, especially as it 
concerns the male germline.   
Immunoflourescence/immunohistochemistry studies show that DNMT1 is expressed in 
gonocytes at embryonic days E13.5 (La Salle et al. 2004), E14.5 and at a lower level at E16.5 
(Sakai et al. 2001). DNMT1 expression is not detectable at E18.5 but resumes expression at 3dpp 
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(La Salle et al. 2004). Thus, DNMT1 is in fact expressed in gonocytes during the window of 
paternal imprint establishment, lending plausibility to its de novo methylation role according to 
our proposed model.  
 
b. Sex-specific function of DNA methyltransferases in the germline 
Different DNA methyltransferases are required for the establishment of paternal and 
maternal imprints. Genetic data demonstrates that Dnmt3l and Dnmt3a are required for 
establishment of maternal imprints in the oocyte (Bourc'his et al. 2001; Kaneda et al. 2004). 
However, deletion of Dnmt3l in the male germline leads to a partial loss of methylation at H19 
(Bourc'his & Bestor 2004). Conditional deletion of Dnmt3b in male germline has no effect on 
paternal imprint methylation. The role of Dnmt3a in de novo methylation of paternal imprints is 
not well understood as variable methylation phenotypes have been reported after conditional 
disruption of Dnmt3a in the male germline (Kaneda et al. 2004; Kato et al. 2007). Thus 
importance of DNMT3A for paternal imprint establishment requires further investigation. Quite 
recently, it has been demonstrated that the newly discovered rodent-specific de novo 
methyltransferase Dnmt3C is required for methylation of Rasgrf1 but not of H19 and Dlk1/Gtl2 
(Barau et al. 2016). As such, the existing literature appears to be clear in establishing that 
methyltransferase DNMT3A and co-factor DNMT3L are required for methylation of maternally 
imprinted genes. However, DNMT3L is dispensable for de novo methylation of paternal ICRs, 
indicating that establishment of imprints in the male germline is mediated by other factors. Our 




c. Phenotypic specificity to paternal differentially methylated regions 
Two possibilities could explain the observation that GR mutants exhibit methylation at 
paternal DMRs but not at maternal DMRs: 1) male germ cells express unknown factor (s) that 
targets DNMT1 to paternal imprints, or 2) paternal DMRs carry an intrinsic signal that recruits 
DNMT1. 
Since experiments were performed in male ES cells, it cannot be excluded that those cells 
express a germline-specific protein or RNA that targets DNMT1 to the paternal DMRs. To 
further investigate the influence of sex  and sex-specific factors on the phenotype of GR cells, it 
would be interesting to generate the same mutation in female ES cells. Unfortunately, female ES 
cells are not desirable for use in methylation studies since they lose methylation over time (Ooi 
et al. 2010), and are known to randomly lose one X chromosome (Eggan et al. 2002).  
 
d. Distinction between paternal and maternal imprints 
We show that GR DNMT1 deposits ectopic methylation specifically at paternally 
imprinted genes, while having no effect on maternal imprints, which reflects a well-established 
sexual dimorphism in genomic imprinting (Bourc'his & Bestor 2006).  There are several notable 
differences between paternal and maternal DMRs. First, only three paternal DMRs are known, 
while about 20 maternal DMRs have been characterized to date (Duffié & Bourc'his 2013). 
Second, paternal DMRs have lower CpG density than the maternal DMRs and are located in 
intergenic regions, while maternal DMRs have higher CpG density and are found within 
promoters (Kobayashi et al. 2006; Bourc'his & Bestor 2006). Third, paternal imprints are 
established early in the developing male germline around the time of birth, while maternal 
imprints are established in the growing oocyte before ovulation (Bourc'his & Bestor 2006; 
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Schaefer et al. 2007). Fourth, in addition to methyltransferases, different chromatin factors may 
be required for maternal versus paternal imprint establishment. For example, KDM1B, a histone 
H3 lysine 4 demethylase, is necessary for methylation of four maternal imprints (Ciccone et al. 
2009), while methylation of paternally imprinted Rasgrf1, but not of H19 or Dlk1/Gtl2, is 
dependent on PIWI (Watanabe et al. 2011). 
In summary, the published literature demonstrates that 1) DNMT1 is expressed in 
gonocytes during the acquisition of paternal imprinting; 2) DNMT3A, DNMT3L and DNMT3C 
seem to have only partial roles in paternal imprint establishment; and 3) there is a well-
characterized difference between paternal and maternal imprints supporting our own observed 
phenotype. We predict that DNMT1 expressed in gonocytes between E14.5-16.5 is found in the 
unacetylated form, and this lack of acetylation allows DNMT1 to carry out de novo methylation 
at paternally imprinted DMRs.  
Significantly, these findings have demonstrated that maintenance and de novo 
methylation activities are not as distinctly separated as previously thought. In fact, in vitro 
studies have shown that DNMT1 has greater affinity towards unmethylated DNA than de novo 
methyltransferases DNMT3A and DNMT3B (Okano et al. 1998). To date, all of the studied 
domains of DNMT1 were shown to be important for its maintenance activity (Leonhardt et al. 
1992; Song et al. 2011). The (GK) repeats are therefore the first identified motif of DNMT1 that 
is important for its de novo methyltransferase function in vivo.  
 
e. Future directions 
To further test our model, we propose several additional experiments. 
Immunofluorescence/immunohistochemistry should be performed to test for the presence of the 
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unacetylated form of DNMT1 in gonocytes at E14.5-16.5. The caveat to this experiment is that 
low levels of the protein might not be detectable, especially when compared to the neighboring 
somatic cells in the developing testes. Gonocytes could also be isolated by cell sorting to perform 
experiments on a purified population without any contamination of somatic tissue.  
To test whether unacetylated DNMT1 plays a role in the establishment of paternal 
imprints in vivo, a loss-of-function mutation consisting of permanently acetylated lysines within 
the (GK) repeats should be engineered in the mouse. Scientists have traditionally used glutamine 
to mimic acetyl-lysine(Kamieniarz & Schneider 2009). However, due to the differences in 
structure lysine to glutamine substitution is not appropriate for the study of the role of acetylation 
in vivo (Kamieniarz & Schneider 2009). To this end, orthogonal aminoacyl-tRNA synthetase 
(aaRS)/tRNA pair method has been developed to genetically incorporate non-canonical amino 
acids into endogenous proteins (reviewed by (Xiao & Schultz 2016). The most recent paper 
describes genetic incorporation of six acetyl-lysines into histone H3 in mouse ES cells (Elsässer 
et al. 2016). While this method is promising and remains the method of choice to study the role 
of the (GK) repeats in the germline directly, it requires several steps of genetic manipulations 
and has not been applied to mutagenesis in the mouse as of yet.  
To further confirm the phenotype of the GR mutation at the endogenous level in ES cells, 
CRISPR/Cas9 technology can be used to substitute lysines within the (GK) repeats with 
arginines in the endogenous Dnmt1 locus in wild-type ES cells (Ran et al. 2013; Doench et al. 
2016). Since wild-type cells carry methylation only at one allele at imprinted genes, we postulate 
that the GR mutant would exhibit a gain of methylation at the second allele of paternally 
imprinted genes. The technical challenge of this experiment lies in the fact that the coding 
sequence for the (GK) repeats is split between two exons. Targeting two separate but relatively 
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adjacent genomic sequences simultaneously using CRISPR/Cas9 might be challenging as it 
would most likely lead to the deletion of the sequence between the two cut sites. This issue could 
be addressed by a two-step mutagenesis of the (GK) repeats: first targeting half of the motif in 
one exon, and then targeting the other half of the repeats in the downstream exon. This 
experiment also requires that both alleles acquire the exact mutation. To this end, using the 
CRISPR/Cas9 system I have developed a heterozygous ES cell line harboring a deletion of the 
1kb genomic sequence encoding the BAH domains and the (GK) repeats. This allows for the 
remaining wild-type allele of Dnmt1 to be targeted with greater efficiency. This cell line exhibits 
normal methylation status due to the fact that Dnmt1 mutation is not haploinsufficient(E. Li et al. 
1992), and therefore it would be useful for the creation of various point mutations within the 
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CHAPTER III. USP7-INDEPENDENT REGULATION OF DNMT1 EXPRESSION 
(Manuscript #1) 
 
III.1. Rationale and Summary 
DNMT1 is present in nuclei at constant levels throughout the cell cycle (Estève et al. 
2011), and is recruited to hemimethylated sited at replication foci during S phase to copy the 
methylation pattern (Leonhardt et al. 1992). There has been an interest in the field to identify the 
role of DNMT1 during G1 and G2 cell cycle phases, when it exhibits diffuse nucleoplasmic 
distribution. Recently a model has been postulated linking DNMT1 biosynthesis and degradation 
to cell cycle (Du et al. 2010). This model suggests that DNMT1 levels during cell cycle are 
controlled by an acetylation-ubiquitination coupled mechanism, which involves interactions with 
the deubiquitinase USP7 and acetyltransferase TIP60 (Du et al. 2010).  
Ubiquitin-specific protease 7 (USP7; also known as Herpes-associated ubiquitin-specific 
protease or HAUSP) is a critical regulator of p53 and MCM2 stability (M. Li et al. 2002; Hu et 
al. 2006; Sheng et al. 2006). It has been reported that during S phase USP7 binds to unacetylated 
(GK) repeats of DNMT1 and stabilizes it by deubiquitination (Cheng et al. 2015). Later in S 
phase and during early G2 phase, TIP60 acetylates the (GK) repeats, which results in the 
dissociation of DNMT1/USP7 complex (Du et al. 2010), ubiquitination of DNMT1 at lysine 586 
(RFTS domain) and lysine 997 (BAH2 domain) (Lecona et al. 2016), and proteosomal 
degradation of DNMT1.  
This model was formulated based on in vitro biochemical studies, while any genetic 
analysis is complicated by the fact that Usp7 mutation leads to DNA replication defects (Lecona 
et al. 2016) and cell lethality via p53 misregulation (M. Li et al. 2002). We further test the 
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proposed model by characterizing genetic loss-of-function of USP7 in MEF cells, knocking 
down of USP7 in lung carcinoma H1299 cells, and by expression of DNMT1 carrying point 
mutations of the (GK) repeats that mimic acetylated lysines in vitro thus blocking the interaction 
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It has been reported that USP7 (ubiquitin-specific protease 7) prevents ubiquitylation 
and degradation of DNA methyltransferase 1 (DNMT1) by direct binding of USP7 to the 
glycine-lysine (GK) repeats that join the N-terminal regulatory domain of DNMT1 to the 
C-terminal methyltransferase domain.  The interaction of USP7 and DNMT1 had also 
been reported to depend on the acetylation status of the (GK) repeats. We found that 
DNMT1 was present at normal levels in mouse and human cells that contained 
undetectable levels of USP7, and loss of USP7 did not affect levels of UHRF1 or of 
histone H2A ubiquitylated at lysine 119.  Mutation of the (GK) repeats to (GQ) repeats 
prevents binding of USP7 but did not affect the stability of DNMT1 or the ability of the 
mutant protein to restore genomic methylation levels when expressed in Dnmt1-null ES 
cells under the control of the Dnmt1 promoter.  Furthermore, both USP7 and PCNA 
were recruited to sites of DNA replication in a manner that was independent of the 
presence or absence of DNMT1.  These and other findings call into question the role of 
post-translational regulation of steady state levels of DNMT1, while several lines of 
evidence indicate that homeostasis of DNMT1 is instead controlled primarily at the level 
of transcription. 
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DNMT1 methylates hemimethylated CpG dinucleotides that appear after passage of the 
replication fork during S phase to ensure mitotic inheritance of genomic methylation 
patterns 1.  As shown in figure 1a, DNMT1 bears a large N-terminal region that contains 
multiple functional domains that mediate nuclear import (the NLS domain), the 
suppression of de novo methylation (the CXXC and autoinhibitory domains) 2, two 
bromo-adjacent homology (BAH) domains of unknown function, and a set of glycine-
lysine (GK) repeats consisting of 13 alternating glycine and lysine residues.  The (GK) 
repeats join the N-terminal regulatory domain to the C-terminal methyltransferase 
domain that is closely related in sequence and structure to DNA (cytosine-5) 
methyltransferases from both prokaryotes and eukaryotes 3.  The (GK) repeats are 
conserved among all eukaryotic DNMT1 homologs, all of which are lysine-rich and have 
at least one GK dipeptide between the regulatory and catalytic domains.  GK dipeptides 
are also enriched in the N-terminal tails of histones H2A and H4 (Fig. 1b).  
 
The structures of several mouse and human DNMT1 proteins have been determined 2,4-
6, and in all cases the (GK) repeats are disordered in the crystal structure and not 
resolved, which implies that they do not form stable associations with other domains of 
DNMT1.  The approximate positions of the (GK) repeats of with respect to other 
domains of human DNMT1 are shown in Fig. 1c.  
 
It has been reported that the (GK) repeats are involved in controlling proteosomal 
degradation of DNMT1 via reversible acetylation of lysines within the (GK) repeats 7-11; 
this has been suggested to couple DNMT1 biosynthesis and degradation to the cell 
cycle 9.  Ubiquitin-specific protease 7 (USP7; also known as Herpes-associated 
ubiquitin-specific protease or HAUSP) 12-14 has been reported to bind to the 
unacetylated (GK) repeats of DNMT1 10; the acetylated form does not bind to USP7 and 
has been proposed to undergo ubiquitylation at lysine 586 (RFTS domain) and lysine 
997(BAH2 domain) 15, and to be targeted for proteosomal degradation 7,16. DNMT1 was 
also reported to be required for the recruitment of USP7 to sites of DNA replication in S-
phase nuclei 10. These reports depended on the results of in vitro studies or transfection 
of tagged and mutated forms of DNMT1 into cells that contained normal levels of 
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endogenous DNMT1; the relative levels of endogenous and exogenous DNMT1 were 
not reported and only exogenous DNMT1 was observed. Furthermore, levels of DNMT1 
do not change appreciably during the cell cycle 17, although DNMT1 is not expressed in 
G0 cells 
18. We report here that reduction of USP7 to undetectable levels in mouse and 
human cells does not cause a measurable reduction in content of DNMT1 or in DNA 
methylation, that substitution of the acetylated lysines within the (GK) repeats by 
glutamines does not affect the amount or activity of endogenous DNMT1, and that 




Genetic removal of USP7 does not affect stability or activity of DNMT1. 
Mouse embryonic fibroblasts (MEFs) homozygous for Floxed alleles of Usp7 were 
cultured, immortalized by transfection of an expression construct that encoded SV40 
large T antigen, and infected with a recombinant Adenovirus that drives expression of 
GFP and Cre recombinase. Cultures that showed near-complete infection as measured 
by GFP expression were cultured for 3-5 days and evaluated for expression of USP7 
and DNMT1 by immunoblot.  As shown in Fig. 2a, levels of DNMT1 were not affected 
when USP7 was reduced to undetectable levels.  USP7 was present at normal levels in 
embryonic stem (ES) cells null for Dnmt1 (Fig.2a).  As shown in Fig. 2b, global levels of 
DNA methylation were not notably affected by the removal of USP7, which is consistent 
with the lack of effect on DNMT1 levels upon removal of USP7. The human lung 
carcinoma cell line H1299 was transfected with an expression cassette that drives 
expression of an inducible USP7 shRNA and a stable cell line was derived.  The shRNA 
produced is complementary to nucleotides 2766-2748 of transcript variant 1 and caused 
strong repression of all Usp7 transcript variants. This inducible system allows 
simultaneous induction of shRNA within the entire cell population.  As shown in Fig. 2c, 
shRNA-mediated reduction in USP7 to undetectable levels did not affect expression of 
DNMT1 or UHRF1, and the levels of ubiquitylation of histone H2A at lysine 119 were 
normal.  Fig. 2d shows that global DNA methylation was not measurably affected by the 
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loss of USP7 expression.  These genetic data indicate that removal of USP7 does not 
lead to a significant reduction in DNMT1 or in global DNA methylation. 
 
Mutation of GK repeats results in normal in vivo stability and activity of DNMT1. 
To further investigate the role of the reported interaction of USP7 with the (GK) repeats 
of DNMT1, we substituted the lysine residues within the (GK) repeats that have been 
shown to undergo acetylation 19,20 with glutamines (Fig. 3a), which cannot be acetylated 
but which block the interaction of USP7 and DNMT1 10.  Expression constructs that 
directed production of wild type GK or GK→GQ DNMT1 were transfected into Dnmt1-
null ES cells and stable clones established as described.  Expression was driven by 14 
kb of DNA 5’ of the Dnmt1 gene, which contains the Dnmt1 promoter and other 
regulatory sequences and has been shown to produce DNMT1 at wild type levels 21,22. 
As shown in Fig. 3a, the GK and GQ proteins were expressed at similar levels, even 
though the GQ substitution has been reported to be unable to bind to USP7 10 and 
according to previous reports would have been expected to be unstable. Fig. 3c also 
shows that the GK and GQ proteins were equally effective in rescuing global DNA 
methylation after expression in Dnmt1-null ES cells and that rescue of methylation of 
the IAP retrotransposon is equivalent when the GK and GQ variants of DNMT1 are 
expressed. The data of Figs. 2 and 3 indicate that the steady-state levels of DNMT1 are 
independent of USP7, that removal of USP7 does not affect global DNA methylation, 
and that substitution of the lysines in the (GK) repeats of DNMT1 that have been 
reported to be required for the DNMT1-USP7 interaction and stabilization of DNMT110 
do not affect expression or activity of DNMT1.   
 
Endogenous USP7 localizes to replication foci independently of DNMT1. 
It was reported that the recruitment of USP7 to replication foci is dependent on the (GK) 
repeats of DNMT1 10.  We tested for recruitment of USP7 to replication foci in ES cells 
that were wild type for DNMT1 and in cells that completely lacked DNMT1.  As shown in 
Fig. 3, USP7 colocalizes with the replication focus marker PCNA independently of 
DNMT1.  These data show that USP7 is not recruited to replication foci by DNMT1 and 
are consistent with a recent report in which USP7 is required to maintain an enrichment 
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in SUMOylation and depletion of ubiquitylation at sites of DNA replication that is 
essential for DNA replication 15. DNMT1 is not required for DNA replication, as shown 
by normal DNA replication in Dnmt1-null ES cells.   
 
DISCUSSION 
Several lines of evidence indicate the USP7 does not determine steady state levels of 
DNMT1.  First, DNMT1 levels are independent of the presence of USP7, as shown in 
Fig. 2.  Second, substitution of the GK repeats with GQ repeats, which inhibits the 
interaction of DNMT1 and USP7, does not affect steady state levels of DNMT1 (Fig. 3).  
Third, USP7 localizes to replication foci independently of DNMT1 (Fig 4).  Fourth, 
modification of the endogenous Dnmt1 locus so as to delete the first 118 amino acids of 
DNMT1 caused the accumulation and persistence of truncated but fully active DNMT1 
to ~ 5 times normal levels 23.  This is the only genetically-defined region of DNMT1 that 
affects protein stability. However, this shortened and stabilized form of DNMT1 is 
produced only in growing oocytes and has not been detected in somatic cells 24.  
 
The (GK) repeats are both highly basic and unstructured; they are therefore capable of 
adopting many conformations and would be expected to bind in vitro to many proteins 
that contain acidic pockets, as is the case for USP7.  Overexpression of tagged or 
mutated forms of DNMT1 in cells that express endogenous but undetected DNMT1 at 
wild type levels may lead to oversaturation of DNMT1 binding sites in replication foci 
and lead to ectopic processing of the excess DNMT1 protein.   
 
Despite the numerous reports of post-translational regulation of DNMT1 expression in 
an acetylation-dependent manner 7-11, strong evidence indicates that DNMT1 levels are 
normally controlled at the transcriptional rather than the post-translational level.  Cells 
heterozygous for loss-of-function mutations at Dnmt1 express one-half the amount of 
DNMT1 protein when compared to wild type cells 25, and mice that contain additional 
copies of the Dnmt1 gene overexpress DNMT1 protein 26. DNMT1 is overexpressed in 
Friend Murine Erythroleukemia cells as a result of spontaneous amplification of the 
Dnmt1 gene in this cell line 27.  DNMT1 is present in nuclei at constant levels throughout 
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the cell cycle and is recruited to replication foci during S phase 28.  DNMT1 is down-
regulated in G0 cells, but this is likely to occur at the transcriptional level 
18. Treatment of 
cells with drugs that induce entry into G0 phase will cause a reduction in DNMT1 levels 
due to cell cycle effects rather than a direct effect on DNMT1 stability 18. There is no 
direct evidence of a post-translational mechanism that compensates for reduced or 
increased DNMT1 transcript levels, and changes in Dnmt1 gene dosage result in 
proportionate increases or decreases in DNMT1 protein level.  This is difficult to 
reconcile with the claims of post-translational homeostasis of DNMT1 expression. If 
there is post-translational regulation of DNMT1 protein levels, it must be small in effect 





Stable ES cell lines were generated as described previously21 with the addition of an N-
terminal Flag-HA tag. Point mutations were generated using QuikChange Site-Directed 
Mutagenesis kit (Agilent).  
 
Usp7cl/+ mice 13 were intercrossed to generate homozygous conditional mutant 
embryos. MEFs were derived and then immortalized with SV40 large T antigen. MEFs 
were subsequently infected with Ad–GFP and Ad–Cre–GFP viruses which were 
purchased from Vector Biolabs (Catalogue numbers 1761 and 1710). Cultures that 
showed near complete infection with Ad-Cre-GFP virus as assessed by visualization of 
GFP expression were analyzed after five days.  
 
To generate the inducible Usp7shRNA knockdown cells, H1299 cells were transfected 
with pTRIPZ encoding a Tet-inducible Usp7 short hairpin RNA purchased from Thermo 
Open Biosystems (clone ID: V2THS_172409). 48 hours later Puromycin (5g/mL) was 
added to the transfected cells for two weeks and positive clones were selected. To 




Whole cell extracts were prepared by lysis in RIPA buffer (150mM NaCl, 1% NP-40, 
0.5% Deoxycholic acid, 0.1% SDS, 50mM Tris pH 7.5) and briefly sonicated to disrupt 
genomic DNA, then heated to 100° in SDS and loaded onto SDS-PAGE gels. Proteins 
were transferred to nitrocellulose membrane and blocked in 5% milk, 0.1% Tween20, 
PBS for 1 hour at room temperature. Blots were incubated at 40C overnight with primary 
antibodies in 10% FBS, 0.1% Tween20. Blots were washed with PBST, after incubation 
with DNMT1 antibody blots were washed briefly with PBST and PBS. Antibodies used: 
rabbit polyclonal to DNMT1 (Cell Signaling Technology, 5032 (D63A6) 1:2,500 dilution), 
rabbit polyclonal to USP7 (Bethyl Laboratories, IHC00018; 1:5,000 dilution), rabbit 
monoclonal to Histone H2A monoubiquitylated at Lys119 (Cell Signaling Technology, 8240 
(D27C4); 1:5,000 dilution), rabbit polyclonal to HA tag (Abcam, ab9110, 1:5000), rabbit 
polyclonal to UHRF1 (Bethyl Laboratories, A301-470A, 1:1000), mouse monoclonal to 
alpha-tubulin (Abcam, ab7291, 1:10,000).  
 
Methylation analysis 
Genomic DNA was digested for two rounds with methylation-sensitive enzyme HpaII, its 
isoschizomer MspI as a control, or McrBC. DNA was quantified and ran on 0.8% 
agarose gel, which was stained with ethidium bromide. Southern blot analysis was 
performed with IAP probe generated by PCR. Primers (matching to LTR+GAG) used for 
probe amplification: probe_IAP_F (GGTAAACAAATAATCTGCGC); probe_IAP_R 
(CTGGTAATGGGCTGCTTCTTCC). Agarose gels were transferred to a Nytran SPC 
membrane (GE Healthcare) overnight in 10X SSPE buffer. After crosslinking, 
membrane was prehybridized with 6X SSC, 5X Denhardts, 1% SDS, 10% Dextran 
Sulfate for 1hour at 45° and incubated overnight with IAP probe at 45°. Membranes 
were washed once with 2X SSC, 0.5% SDS; 2X with 1X SSC, 0.5% SDS, and 1X with 
0.2X SSC, 0.5% SDS.  
 
Immunofluorescence  
ES cells were cultured on glass slides. For the PCNA immunostaining, cells were 
treated with 0.5% Triton X-100 in CSK buffer (100 mM NaCl, 300 mM sucrose, 10 mM 
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PIPES [piperazine-N,N-bis(2-ethanesulfonic acid)], pH 6.8, 3 mM MgCl2, 1 mM EGTA) 
for 30 seconds at 4°C, and then treated with methanol for 20 min at -20°C 29. 
Cells were permeabilized/blocked in Block solution (5% Donkey serum, 0.3% Triton, 1X 
PBS), then incubated overnight with primary antibody diluted in Block solution at 40C. 
The following primary antibodies were used: mouse monoclonal to PCNA (Abcam, 
ab29, 1:500 dilution), rabbit polyclonal to USP7 (BethylLaboratories, IHC00018; 1:100 
dilution).  
Cells were washed ten times with PBS and incubated for 1 hour at room temperature 
with the following secondary antibodies diluted in Block buffer: Cy3-conjugated donkey 
anti-mouse (Jackson lmmunoResearch; 1:200 dilution) and IgM Alexa 488–conjugated 
IgG donkey anti-rabbit (Jackson lmmunoResearch; 1:500 dilution). Slides were 
subsequently washed with PBS, counterstained with Hoechst 33342 (Invitrogen) and 




Fig.1.  The (GK) repeats in DNMT1.  a., Domain organization in murine DNMT1.  NLS: 
nuclear localization sequence.  RFTS: replication focus targeting sequence. CXXC: 
Zinc-containing domain that binds to unmethylated CpG sites in double stranded DNA.  
Autoinhibitory: An acidic linker interposed between DNA and the active site of DNMT1 
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when the CXXC domain is bound to unmethylated DNA. BAH1 and 2: Bromo-adjacent 
homology domains that are of unknown function in DNMT1 but are involved in binding 
to specific histone modifications in other proteins.  (GK): The run of alternating glycine 
and lysine amino acids at the junction between the N-terminal regulatory and C-terminal 
catalytic domains of DNMT1.  Methyltransferase domain: Catalytic domain related in 
sequence and structure to eukaryotic and prokaryotic DNA (cytosine-5) 
methyltransferases.  b., Alignment of (GK) repeats of DNMT1 homologs from mammals, 
insects, and plants, and with the N-terminal tails of histones H2A and H4. GK dipeptides 
are outlined in red; the related AK dipeptides are outlined in blue. c., Structure of 
autoinhibited form of human DNMT1 in complex with unmethylated DNA to show spatial 
relationships of domains diagrammed in a.  The protein shown was truncated just N-
terminal of the CXXC domain prior to crystallization.  The (GK) repeats were 
unstructured in all the crystallographic studies of DNMT1; they are shown here roughly 






Fig 2.  Elimination of USP7 does not affect steady state level of DNMT1 or global DNA 
methylation.  a., MEFs that lack USP7 after Cre-mediated excision of a Floxed allele of 
Usp7 show normal levels of DNMT1 (lane 2) but no detectable USP7 protein.  b., 
Normal DNA methylation in MEFs that lack USP7.  McrBC cleaves methylated DNA; 
HpaII cleaves unmethylated DNA at CCGG sites; MspI cleaves CCGG sites whether 
methylated or unmethylated.  DNA from wild type and Usp7–/– MEFs show similar 
patterns of resistance to both McrBC and HpaII.  c., Removal of USP7 by an inducible 
shRNA against USP7 from H1299 human lung carcinoma cells does not affect levels of 
DNMT1, UHRF1, or H2AK119ub1.  d., DNA methylation is not measurably affected by 







Fig. 3.  Substitution of lysines by glutamines within (GK) repeats does not affect DNMT1 
stability or function.  a., Positions of GK→GQ substitutions within the (GK) repeats of DNMT1.  
The substituted lysines correspond to those reported to be acetylated in vivo.  b., Normal stability of 
GK→GQ DNMT1 in stably transfected  Dnmt1-null ES cells.  c., Normal methylation of genomic DNA as 
measured by resistance to HpaII in stably transfected  ES cells at left; at right, equal methylation of IAP 
retrotransposon DNA by wild type and GK→GQ DNMT1.  Three independent GK→GQ clones were 




Fig. 4.  USP7 is recruited to replication foci in the absence of DNMT1. Replication foci 
where identified by staining for the replication factor PCNA.  Colocalization of USP7 and 
PCNA is clearly apparent in both wild type (top three rows) and Dnmt1-null (bottom 
three rows) ES cell nuclei. 
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The results described in the manuscript demonstrate that USP7 does not control levels of 
DNMT1 and plays no regulatory role in maintenance DNA methylation. In addition, USP7 
localization to replication foci is shown to be independent of DNMT1. Our data therefore 
contradicts the established model in the field.  
The detected in vitro binding (Du et al. 2010) and crystal structure (Cheng et al. 2015) of 
DNMT1 and USP7 can be explained by the observation that the (GK) repeats are highly basic 
and unstructured; as a result they could possibly adopt many conformations and bind in vitro to 
proteins with acidic pockets. Moreover, the crystal structure of DNMT1 and USP7 demonstrates 
that the two proteins bind via two interfaces: interface-1 involving the interaction of the (GK) 
repeats with the acidic groove on the surface of UBL1-2 domains of USP7; interface-2 involving 
the TRD of DNMT1 and UBL3 of USP7 (Cheng et al. 2015), suggesting that DNMT1/USP7 
interaction does not exclusively depend on the (GK) repeats. Furthermore, only three lysines 
(K1109, K1111 and K1115) of the (GK) repeats participate in the interaction with USP7 (Cheng 
et al. 2015), while the rest of the (GK) motif is disordered, suggesting that USP7 binding with 
DNMT1 can take place via different modes of binding. Further mutagenesis of residues involved 
in the two interfaces is needed to understand the functional importance of these binding modes in 
vivo.  
An alternative explanation for the interaction of DNMT1 and USP7 could be the requirement 
of DNMT1 for USP7 function at replication foci. A recent report demonstrated that USP7 is, in 
fact, required to maintain a SUMO-rich and Ub-poor chromatin environment at replisomes in 
mammalian cells through the process of deubiquitination of SUMO2/3 (Lecona et al. 2016). We 
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tested whether DNMT1 is required for localization of USP7 to replisomes by performing an 
immunofluorescence experiment, and showed that USP7 localization is DNMT1-independent.  
Little is known about the nature of DNMT1 ubiquitination and proteasome degradation. Two 
lysines (K586 in RFTS domain and K997 in BAH2) were recently identified as possible sites of 
ubiquitination, and deubiquitination by USP7 (Lecona et al. 2016). It is not known which E3 
ubiquitin ligase ubiquitnates these residues. UHRF1 has been suggested as a possible candidate 
(Qin et al. 2011; Du et al. 2010) however protein levels of DNMT1 do not change in UHRF1-
null cells (Sharif et al. 2007; Bostick et al. 2007) demonstrating that UHRF1 does not participate 
in targeting DNMT1 for proteosomal degradation. In addition, it remains uncertain whether 
ubiquitination of lysines 586 and 997, and deubiquitynation by USP7 involves mono- or 
polyubiquitination. Only certain types of polyubiquitynation (K48- and K11-linked) lead to 
proteasomal degradation of proteins, while monoubiquitynation and other forms of 
polyubiquitination (K63-linked) perform other regulatory functions such as kinase activation, 
signal transduction, endocytosis and others (Sadowski et al. 2012). While many of the details 
bear further investigation, it seems clear that in general USP7 is not involved in regulation of 
DNMT1 stability, nor in maintenance DNA methylation.  
 
a. Manuscript contributions 
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performed by O.Y. Usp7–null MEF and H1299 cells were provided by O.T. and W.G.  
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CHAPTER IV. THE ROLE OF BAH DOMAINS IN REGULATING DNMT1 
LOCALIZATION AND FUNCTION. 
 
IV.1. Rationale and Summary 
DNMT1 contains two tandem Bromo-Adjacent-Homology (BAH) that have a dumbbell-
shaped configuration in the crystal structure (Song et al. 2011; Song et al. 2012; Takeshita et al. 
2011). Their function or role in DNA methylation is unknown.  
Both BAH domains are positioned on the surface of the DNMT1 molecule remote from 
the bound DNA at the active site, although they are each connected to the rest of the molecule 
via long linkers: BAH1 connects to the CXXC domain via the autoinhibitory linker (Song et al. 
2011), and BAH2 contains a long protruding loop that makes interactions with the TRD (Song et 
al. 2012). While the crystal structure suggests that the BAH domains could not have a direct 
effect on the catalytic site of DNMT1, they might possess regulatory functions via interactions 
with other proteins given their large, exposed surface area.  
In addition to DNMT1, BAH domains are found in proteins involved in chromatin 
remodeling such as ASH1 (also known as KMT2H), MTA1, MTA2, RSC1, RSC2, Sir3 and 
ORC1 (Yang & R.-M. Xu 2013). Recently, it has been shown that BAH domains in Sir3 and 
ORC1 proteins are histone-binding modules (Armache et al., 2011; Kuo et al., 2012) that 
recognize specific histone modifications. ORC1 selectively binds to histone H4K20me2 (Kuo et 
al. 2012), while Sir3 makes several contacts with nucleosome containing unmodified H4K16 and 
H3K79 (Armache et al. 2011). Therefore, we hypothesized that the BAH domains of DNMT1 
might regulate targeting of DNMT1 based on the interaction with specific chromatin 
modifications, and we set out to test this using genetic, biochemical and structural approaches, 
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specifically CRISPR/Cas9 to delete BAH domains, genetic rescue with point mutations in the 




IV. 2. Materials and Methods 
a. Cell lines and cell culture 
Mouse ES cells were cultured on gelatin following standard techniques. Stable ES cell lines were 
generated by nucleofection of Dnmt1-null ES cells (Lei et al. 1996) with MT80 minigene (Figure 
2A) and pGKPuro plasmid for Puromycin resistance. MT80 minigene, carrying 12kb of 5’ 
Dnmt1 genomic sequence with endogenous promoter and 5.5kb of Dnmt1 cDNA (Tucker, 
Talbot, et al. 1996; Damelin & Bestor 2007), was modified by the addition of the N-terminal 
Flag-HA tag after the translation start site. Point mutations were produced using QuikChange 
Site-Directed Mutagenesis kit (Agilent). Individual clones were selected with Puromycin for 10-
14 days and picked into 96-well plates.  Clones were genotyped using primers specific to the 
Flag-HA tag . Positive clones were propagated and levels of DNMT1 expression were tested by 
Western blotting. Clones expressing DNMT1 at wild-type levels were used for further studies. 
 
b. CRISPR mutagenesis 
Broad Institute software was used to design gRNAs targeting intron 23-24  
(Forward oligo: CACCGATAAAAACCAAGCCTGATGG; Reverse oligo: 
AAACCCATCAGGCTTGGTTTTTATC) and intron 29-30  
(Forward oligo: CACCGCAGACGCTAGGCTAATCCT; Reverse oligo: 
AAACAGGATTAGCCTAGCGTCTGC) of endogenous Dnmt1. gRNAs were cloned into 
pX330-PURO plasmid and nucleofected into wild-type ES cells. Transient selection was applied 
for 24 hours, and surviving clones were picked 10-14 days after nucleofection. Remaining clones 
were pulled for genomic DNA and tested with T7 endonuclease to check the percentage of cuts 
in the population. Individual clones were genotyped using primers flanking the deletion site (F: 
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CAGGTAGCCCATCCGCTTG; R: AATTCCTAGCACCCACACGG). Homozygous and 
heterozygous clones were distinguished by using one primer inside the deleted site and one 
primer outside.  
 
c. Immunoblotting 
Whole cell extracts were prepared by lysis in RIPA buffer (150mM NaCl, 1% NP-40, 0.5% 
Deoxycholic acid, 0.1% SDS, 50mM Tris pH 7.5) and briefly sonicated to disrupt genomic 
DNA, then heated to 100° in SDS and loaded onto SDS-PAGE gels. Proteins were transferred to 
nitrocellulose membrane and blocked in 5% milk, 0.1% Tween20, PBS for 1 hour at room 
temperature. Blots were incubated at 4
0
C overnight with primary antibodies in 10% FBS, 0.1% 
Tween20. Blots were washed with PBST, after incubation with DNMT1 antibody blots were 
washed briefly with PBST and PBS. Antibodies used: rabbit polyclonal to DNMT1 (Cell 
Signaling Technology, 5032 (D63A6) 1:2,500 dilution), rabbit polyclonal to USP7 (Bethyl 
Laboratories, IHC00018; 1:5,000 dilution), rabbit monoclonal to Histone H2A 
monoubiquitylated at Lys119 (Cell Signaling Technology, 8240 (D27C4); 1:5,000 dilution), 
rabbit polyclonal to HA tag (Abcam, ab9110, 1:5000), rabbit polyclonal to UHRF1 (Bethyl 
Laboratories, A301-470A, 1:1000), mouse monoclonal to alpha-tubulin (Abcam, ab7291, 
1:10,000).  
 
d. Methylation analysis 
Genomic DNA was digested for two rounds with methylation-sensitive enzyme HpaII 
(recognition sequence CCGG), its isoschizomer MspI as a control, or McrBC. DNA was 
quantified and ran on 0.8% agarose gel, and stained with ethidium bromide.  
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e. Southern blots 
Southern blot analysis was performed with IAP probe generated by PCR. Primers (matching to 
LTR+GAG) used for probe amplification: probe_IAP_F (GGTAAACAAATAATCTGCGC); 
probe_IAP_R (CTGGTAATGGGCTGCTTCTTCC). Probes for minor and major satellites were 
prepared by EcoRI digestion from plasmids (gift of Mathieu Boulard). Agarose gels were 
transferred to a Nytran SPC membrane (GE Healthcare) overnight in 10X SSPE buffer. After 
crosslinking, membrane was prehybridized with 6X SSC, 5X Denhardts, 1% SDS, 10% Dextran 
Sulfate for 1hour at 45° and incubated overnight with IAP probe at 45°. Membranes were 
washed once with 2X SSC, 0.5% SDS; 2X with 1X SSC, 0.5% SDS, and 1X with 0.2X SSC, 
0.5% SDS.  
 
f. Immunofluorescence  
ES cells were cultured on glass slides. For the PCNA immunostaining, cells were treated with 
0.5% Triton X-100 in CSK buffer (100 mM NaCl, 300 mM sucrose, 10 mM PIPES [piperazine-
N,N-bis(2-ethanesulfonic acid)], pH 6.8, 3 mM MgCl2, 1 mM EGTA) for 30 seconds at 4°C, and 
then treated with methanol for 20 min at -20°C (Takebayashi et al. 2007). Cells were 
permeabilized/blocked in Block solution (5% Donkey serum, 0.3% Triton, 1X PBS), then 
incubated overnight with primary antibody diluted in Block solution at 4
0
C. The following 
primary antibodies were used: mouse monoclonal to PCNA (Abcam, ab29, 1:500 dilution), 
rabbit polyclonal to USP7 (BethylLaboratories, IHC00018; 1:100 dilution). Cells were washed 
ten times with PBS and incubated for 1 hour at room temperature with the following secondary 
antibodies diluted in Block buffer: Cy3-conjugated donkey anti-mouse (Jackson 
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lmmunoResearch; 1:200 dilution) and IgM Alexa 488–conjugated IgG donkey anti-rabbit 
(Jackson lmmunoResearch; 1:500 dilution). Slides were subsequently washed with PBS, 
counterstained with Hoechst 33342 (Invitrogen) and mounted with Vectorshield mounting 
medium (Vector Labs). 
g. Protein purification 
pRSF-Dnmt1 plasmid (with 6xHis tag) for expression of recombinant truncated DNMT1 with 
BAH1, BAH2 and catalytic domains was a kind gift of Dr. Jikui Song. pRSF-DNMT1 was 
modified using QuikChange Site-Directed Mutagenesis kit (Agilent) to introduce STOP codons 
after BAH2 domain (for generation of BAH1-BAH2 recombinant DNMT1) and after BAH1 
domain (for generation of BAH1 recombinant protein). Dnmt1 sequence was also subcloned into 
pGEX-6P-1 GST expression vector. Recombinant proteins were expressed in BL21(DE3)RIL E. 
coli cells and grown at 37C until OD600 reached 0.6. Temperature was then changed to 18C and 
cells were induced with 0.4mM IPTG overnight. Recombinant proteins were purified using a 
modified protocol from (Song et al. 2011). One step purification was performed using Ni-NTA 
beads (ThermoScientific, 88221). Purified proteins were dialized overnight in 20mM Tris-HCl, 
7.5; 200mM NaCl and 5mM DTT, and stored at -80C. 
 
h. Histone peptide array 
Histone peptide arrays were purchased from ActiveMotif. Arrays were briefly blocked in 5% 
milk and incubated with fresh recombinant proteins for 1 hour at 4C. Binding was detected using 




i. In vitro pull-down of ES cell extracts and recombinant proteins 
Nuclear extracts from Dnmt1
c/c 
ES cells were prepared using detergent-based buffer for lysis and 
Dounce homogenizer, and subsequently digested with MNase to acquire mononucleosomes. At 
the same time purified recombinant proteins were bound to magnetic nickel beads, and then 
incubated with the nuclear extract overnight at 4
o
C. Proteins were eluted using acidic elution 
with Glycine. Eluted proteins were resolved on SDS-PAGE gel. Two bands were cut out and 
sent for mass spectrometry analysis at Harvard University. 
 
j. Structural analysis 
BAH1 and BAH2 structures were analyzed using Cn3D and Pymole programs. 3D sequence 






a. Deletion of BAH domains results in stable DNMT1 protein 
To study the function of BAH domains in mouse ESCs we utilized CRISPR/Cas9 technology 
to create a deletion of the exons 24-29, encoding the BAH1 and BAH2 domains, in the 
endogenous locus of Dnmt1 (Figure 4A(a)). The deletion of exons 24-29 does not alter the frame 
of the RNA messenger produced by splicing of exon 23 to exon 30. Cas9 was targeted to make 
cuts in the introns just upstream of exon 24 and downstream of exon 29. 22.5% of genotyped 
clones were homozygous for the desired deletion. Two homozygous clones were selected for 
analysis and one clone with unaltered wild-type alleles served as a control.  
In-frame deletion of BAH domains had no effect on DNMT1 stability in vivo. Fig. X 
shows that DNMT1
ΔBAH
 was produced at levels similar to wild type with the expected size of 
150 kDa. No degradation products were detected, arguing that DNMT1
ΔBAH
 is stable. 
Importantly, antibody recognizing an epitope within the BAH2 domain failed to detect any 
protein for either clone (Figure 4A(b)).  Our CRISPR/Cas9 strategy yielded production of wild 
type levels of DNMT1 protein lacking BAH domains from the endogenous locus.  
 
b. BAH domains are required for global maintenance of DNA methylation 
Global methylation levels of DNMT1
ΔBAH
 clones were determined by digestion of genomic 
DNA with the methyl-sensitive restriction enzyme HpaII, which is inhibited by methylation at 
CpG sites. Figure 4B(a) shows that both DNMT1
ΔBAH
 clones exhibit genome-wide 
demethylation similar to Dnmt1
-/-
 ESCs. Hence, we can conclude that BAH domains of DNMT1 
are required for global methylation in ESCs.  
 
 96 
c. BAH domains are required for methylation at different genomic compartments to variable 
degrees 
To examine the methylation status of DNMT1
ΔBAH
 clones at different genomic sequences, 
Southern blot analysis was performed with probes against IAP retrotransposons, minor and 
major satellite repeats. To analyze methylation at major satellites genomic DNA was digested 
with MaeII (HpyCH4IV) restriction enzyme, since there are no HpaII sites within the major 
satellite sequence. Figure 4B shows that both IAPs and major satellites lose methylation upon 
deletion of the BAH domains, while minor satellites retain partial methylation. These data 
indicate that DNMT1’s BAH domains are required for maintenance methylation at 
retrotransposons and major satellites, while they are only partially required for methylation at 




FIGURE 4A. Deletion of BAH domains at the endogenous locus yields stable protein at wild-
type levels. a., Endogenous locus of Dnmt1 was targeting using CRISPR/Cas9 resulting in 
complete deletion of BAH domains, while allowing in frame splicing. b., Two homozygous 





FIGURE 4B. ES cells with BAH deletion exhibit genome-wide demethylation. a., Genomic 
DNA was digested with methyl-sensitive enzyme HpaII and resolved on an agarose gel (left), 
subsequently probed with IAP (middle) and minor satellite (right) probes. b., For major satellite 
Southern blot, DNA was digested with MaeII. IAP and major satellites exhibit complete 
demethylation, while minor satellites retain partial methylation. 
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FIGURE 4C. DNMT1BAH clones exhibit mislocalization of the protein during S phase. a., 
Replication foci where identified by staining for the replication factor PCNA. Wild-type cells 
show colocalization of full-length DNMT1 and PCNA. b., Quantification of cells with DNMT1 








FIGURE 4D. Figure 4D. Identification of BAH1 and BAH2 binding pockets. Protein sequence 
of DNMT1’s BAH domains was aligned with BAH of ORC1 and Sir3 using a 3D sequence 
alignment tool VAST. Residues that constitute binding pockets are outlined. Predicted BAH1 
and BAH2 binding residues are in red. a., 3D structural alignment; b., sequence alignment based 






FIGURE 4E. BAH domains bind to methylated H3K27 and acetylated H2B peptides in vitro.  
a., Truncated DNMT1 with BAH1, BAH2 and methyltransferase domains was purified. b., 
Recombinant protein was incubated with a histone peptide array (ActiveMotif). Binding was 





FIGURE 4F. BAH1 and BAH2 bind to methylated H3K27 and acetylated H2B peptides in vitro. 
a., Truncated DNMT1 with BAH1 and BAH2 was purified. b., Recombinant protein was 
incubated with a histone peptide array (ActiveMotif). Binding was detected with antibodies 






FIGURE 4G. BAH1 alone can bind to methylated H3K27 and acetylated H2B peptides in vitro. 
a., BAH1 tagged with a GST-tag was purified. b., BAH1 was incubated with a histone peptide 
array (ActiveMotif). Binding was detected with antibodies against the GST-tag. 
 
 
FIGURE 4H. Identification of BAH1 potential binding partners in vitro. Purified recombinant 
BAH1 domain or BAH1Y778A were incubated with the nuclear extract from Dnmtc/c ES cells. 
Eluted proteins were resolved on an acrylamide gel. Bands present in the BAH1 lane and 
absent in the BAH1Y778A lane were excised and sent for mass spectrometry analysis. 
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FIGURE 4I. Point mutation in BAH1 is not sufficient to disrupt its function. a., BAH1 point 
mutation does not effect DNMT1 stability. Stable clones expressing wild-type levels of DNMT1 
were further analyzed. b., Position of Y778A substitution within the BAH1. c., Normal 
methylation of genomic DNA as measured by resistance to methyl-sensitive restriction enzyme 
HpaII; Southern blot analysis with probes for IAP retrotransposon and Minor Satellites revealed 







FIGURE 4J. Structural model of DNMT1 recruitment to nucleosomes via its BAH domains. 
BAH domains of DNMT1 might contribute to proper localization during S phase by recognition 
of specific histone marks on nucleosomes. Modeling was done using Pymol by alignment of 





d. Deletion of BAH domains prevents targeting of DNMT1 to replication foci during S phase 
To investigate subcellular localization of DNMT1
ΔBAH
, immunofluorescence studies were 
performed with antibodies against PCNA to mark replication foci and cells in S phase as well as 
against DNMT1, using an epitope within the methyltransferase domain. In wild-type cells 
DNMT1, is targeted to replication foci during S phase (Leonhardt et al. 1992), so that co-
localization pattern between PCNA and DNMT1 was observed in wild type control cells. 
Strikingly, both DNMT1
ΔBAH
 clones exhibited loss of DNMT1 at replication foci during S phase, 
displaying instead a diffuse signal across the nucleus similar to that seen in non-S phase cells 
(Figure 4C). This phenotype was observed for all mutant S phase cells demonstrating that the 
BAH domains are necessary for targeting of DNMT1 to replication foci during S phase. Thus, 
the global loss of methylation phenotype seen in these mutants originates from the failed 
targeting of DNMT1
ΔBAH
 to the replication foci.  
 
e. BAH1 domain is predicted to be a histone-binding domain 
Since ORC1 and Sir3 were shown to be histone-binding domains(Sampath et al. 2009; 
Armache et al. 2011; Kuo et al. 2012) we hypothesized that either one or both of the BAH 
domains of DNMT1 might also bind to specific histone modifications. To identify the potential 
histonebinding pockets of BAH1 and BAH2, 3D sequence alignments were performed with 
BAH domains of ORC1 and Sir3 (Gibrat et al. 1996). Individual residues of BAH1 and BAH2 
binding pockets were identified based on their spatial alignment against the residues from the 
known histone-binding pockets of ORC1 and Sir3 (Figure 4D). 3D sequence alignment revealed 
that BAH1’s pocket is composed of tyrosine 778, tryptophan 798, aspartic acid 804, glutamic 
acid 821 and valine 819. BAH2’s pocket is composed of arginine 995, lysine 1021, tyrosine 
 107 
1023, asparagine 1027 and tyrosine 1023. The BAH1 binding pocket thus shows close 
conservation with ORC1’s, implicating it as a potential methyllysine-recognizing domain. In 
contrast, the BAH2 pocket is quite divergent, acquiring positively charged arginine and lysine 
residues instead of the conserved tyrosine and tryptophan, leading to the conclusion that the 
BAH2 domain might have another function than histone binding.  
 
f. BAH1 domain recognizes specific modifications on histone tails in vitro 
To identify if the BAH1 domain binds to histone tails an unbiased in vitro screen was 
performed using a commercial histone peptide array with 384 combinations of histone 
modifications spotted onto a cellulose membrane. To this end the following truncated 
recombinant proteins were purified from E. coli: BAH1 domain, BAH1-BAH2 tandem domains 
and BAH1-BAH2-MTase (Figure 4E(a); 4F, 4G(b)).  Purified truncated proteins were incubated 
with the histone peptide arrays and binding was detected with antibodies against the tag epitope 
on the recombinant protein. Both BAH domains recognized histone H3 mono-, di- and 
trimethylated at lysine 27 and histone H4 acetylated at lysines 12 and 15 (Figure 4E(b); 4F). 
Furthermore, the BAH1 domain alone could recognize all of these modifications (Figure 4G(a), 
demonstrating that histone-binding ability is confided mostly to the BAH1 domain. Importantly, 
this experiment was performed with BAH1 tagged with either His-tag or a GST-tag and yielded 
the same pattern of recognition, ruling out any artifactual binding due to tags or antibodies.  
Interestingly, it was observed that BAH1’s interaction with H3 lysine 27 was blocked by 
phosphorylation of serine 28 (Figure 4E(b); 4F; 4G(a).  
To further confirm histone targets of BAH1, fluorescent polarization (FP) was performed 
with purified BAH1 and fluorescently-tagged tail of histone H3 trimethylated at lysine 27. FP 
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failed to detect an interaction between BAH1 and H3K27me3. Other modifications identified on 
the array were not tested due to the costly nature of this technique. 
 
g. BAH1 domain binds to chromatin factors in vitro 
To identify potential non-histone interaction partners of the BAH1 domain, a pull-down 
experiment was performed in which purified wild-type BAH1 domain or mutated BAH1, with 
substitution of a conserved tyrosine 778 to alanine (BAH1
Y778A
), were incubated with nuclear 
extract from Dnmt1
-/-
 ESCs. After the pull-down, proteins were resolved on an acrylamide gel; 
bands present in the BAH1 lane and absent in the BAH1
Y778A
 lane were excised and sent for 
mass spectrometry analysis (Figure 4H). The following proteins were identified as potential 
interaction partners of BAH1: histone H1 and a number of factors involved in chromatin 
remodeling, namely RUVBL1, RUVBL2, GATAD2A, RBBP4 (also known as chromatin 
assembly factor 1 subunit C and RBAP48) and SMARCE1 (Figure 4H). Histone H1 has 
previously been reported to be involved in the maintenance of methylation at imprinted control 
regions in mammals (Fan et al. 2005) and plants (Rea et al. 2012). It should be noted that histone 
H1 was not present on the histone peptide array and that core histones were not detectable in our 
assay because proteins with molecular weight below 25kDa were not analyzed by mass 
spectrometry. The putative interacting partners identified in this pull-down experiment have to 
be further validated.  
 
h. Point mutation in BAH1 binding cage is not sufficient for disruption of BAH1 function 
To understand more precisely the mechanism of BAH1 function we utilized a genetic rescue 
system as described in Chapter 2. Expression of Dnmt1 was driven by 12kb of DNA 5’ of the 
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Dnmt1 gene, which contains the endogenous Dnmt1 promoter and other regulatory sequences 
necessary for expression of DNMT1 at wild-type levels (Tucker, Talbot, et al. 1996; Damelin & 
Bestor 2007). A point mutation in the BAH1 domain was introduced that lead to the production 
of DNMT1 with substitution of conserved tyrosine 778 to alanine (Y778A) (Figure 4I(a)).  A 





 were expressed at levels similar to that of endogenous 
DNMT1 in wild type cells, suggesting that Y778A substitution does not affect the stability of 
DNMT1. 





digestion of genomic DNA with the methyl-sensitive restriction enzyme HpaII. We observed that 
DNMT1
Y778A
 rescues global methylation levels to wild-type levels similarly to DNMT1
WT
 
(Fig. 4I(c)).  Further Southern blot analysis revealed that DNMT1
Y778A
 is able to normally 
methylate IAP retrotransposons and minor satellite repeat sequences (Fig. 4I(c)), indicating that 
BAH1 point mutation does not compromise the maintenance methyltransferase activity of 
DNMT1. We cannot exclude the possibility that this single substitution did not sufficiently 
disrupt BAH1 binding pocket; simultaneous substitution of several or all binding pocket residues 






The data presented in this chapter demonstrate that the BAH domains of DNMT1 are 
required for its targeting to replication foci during S phase, and this targeting possibly involves 
interaction with histones (Figure 4J). Expression of DNMT1 with deleted BAH domains in 
mouse ES cells leads to mislocalization of the protein and, consequently leads to global genome 
demethylation. In vitro studies using histone peptide arrays, structural analysis and pull-down 
experiments identified BAH1 as a histone-binding domain. Expression of DNMT1 harboring a 
point mutation in BAH1 domain exhibited normal methylation suggesting that the entire binding 
pocket should be substituted for future BAH1 loss-of-function studies.  
 
a. Proper targeting of DNMT1 is required for maintenance methylation 
During S phase DNMT1 localizes to the replication foci to carry out methylation of the 
newly replicated DNA (Leonhardt et al. 1992). This localization depends on RFTS domain 
(Leonhardt et al. 1992), presence of methylated cytosines (Damelin & Bestor 2007; Takebayashi 
et al. 2007), and ubiquitin ligase UHRF1, which binds to RFTS of DNMT1 and selectively 
recognizes hemimethylated CpG sites via its SRA domain(Bostick et al. 2007; Sharif et al. 
2007). It was thought that UHRF1’s recognition of histone H3 lysine 9 methylation is required 
for maintenance DNA methylation, but a UHRF1 mutant incapable of binding to histones has 
only a slight effect on DNA methylation levels (Zhao et al. 2016) showing that recognition of 
hemimethylated DNA by UHRF1 is necessary and sufficient for proper targeting  and 
methylation by DNMT1. 
Surprisingly, we found that the BAH domains are also required for proper targeting of 
DNMT1 during S phase and that presence of a functional RFTS domain cannot compensate for 
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the loss of this BAH-associated function. Our data suggests that both the RFTS and BAH 
domains are necessary and sufficient to target DNMT1 to replication foci.  
We suggest that BAH domains target DNMT1 to replisomes by interaction with specific 
histone modifications (Figure 4J). We identified the following possible interaction partners of the 
BAH1 domain: methylated lysine 27 of histone H3 (H3K27me), acetylated histone H2B 
(H2Bac), and linker histone H1.  
H3K27 trimethylation is catalyzed by EZH2, a component of Polycomb Repressive 
Complex 2 (PRC2) (Simon & Kingston 2009). Recent genome-wide analysis using sequential 
ChIP-bisulfite-sequencing (ChIP-BS-seq) identified that DNA methylation and H3K27me3 co-
occur in mammalian cells in general, but they are mutually exclusive in CpG-dense regions 
(Brinkman et al. 2012). In addition, loss of DNA methylation in ES cells is associated with the 
establishment of broad domains of H3K27me3 at regions that were marked by high DNA 
methylation in wild-type cells (Brinkman et al. 2012). The link between DNA methylation and 
H2B acetylation has been previously established in the filamentous fungus Neurospora crassa, 
where mutation of histone deacetylase hdac-1, which uses H2B as its substrate, results in DNA 
methylation defect (K. M. Smith et al. 2010). Analysis of triple H1-null ES cells demonstrated 
decreased methylation at some imprinted genes (H19, Igf2, Dlk1, Gtl2), leading to their 
misexpression, while global DNA methylation levels were normal (Fan et al. 2005). Therefore, 
DNA methylation has an antagonistic relationship with H3K27me3 and H2B acetylation, 
suggesting that DNMT1 could be excluded from chromatin domains harboring these histone 
modifications via an inhibitory interaction of the BAH1 domain. On the other hand, linker 
histone H1 associated with DNA methylation at imprinted genes suggesting an activating 
interaction between DNMT1 and H1 at these genomic regions.  
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In accordance with previous work characterizing BAH domains in other proteins as a 
histone-recognizing modules (Kuo et al. 2012; Armache et al. 2011), our structural and sequence 
analysis suggests that the BAH1 domain of DNMT1 could function similarly, but BAH2 is 
unlikely to participate in such interactions due to non-conservative substitutions in its binding 
pocket and anchoring of the BAH2-TRD loop to the binding pocket.  
We observed differential methylation of several distinct genomic compartments in BAH 
mutants. While IAP retrotransposons and major satellites lost all genomic methylation, minor 
satellite sequences retained partial methylation. Interestingly, major satellites are more abundant 
in the genome than minor satellites (Guenatri et al. 2004), so the observed difference in 
methylation is not due to the number of repeats or sensitivity of the probe. Major and minor 
satellites both possess trimethylated lysine 9 of histone H3 (Peters et al. 2001), though they have 
different sensitivities to micrococcal nuclease (Guenatri et al. 2004). In addition, DNMT3B is 
required for de novo methylation of minor satellite sequences (Okano et al. 1999). Importantly, 
we see that DNMT1 with BAH deletion clearly possesses enzymatic activity in vivo, though, at 
present, it is not clear why this truncated version of the enzyme has a preference for minor 
satellites.  
 
b. Future directions 
 In order to further dissect the mechanism of function of BAH domains, I propose the 
following experiments: 
1) To test loss-of-function of BAH1 domain specifically, our rescue experiment shows 
that it is necessary to mutate all of the residues that form the predicted histone-
 113 
binding cage. I propose to utilize the MT80 system to re-introduce Dnmt1 carrying 
point mutations in all five residues of the binding cage.  
2) To confirm BAH1 interaction partners from histone peptide array and pull-down 
experiments, further biochemical confirmation and target validation is necessary. A 
possible orthogonal approach to this proof is the use of the BioID system to identify 
in vivo protein-protein interactions (Roux et al. 2012) between DNMT1 and its 
targets. The caveat of this experiment is that BioID tagging is based on the proximity 
of two proteins and doesn’t necessarily mean their direct interaction. Nevertheless, 
comparison of targets from our biochemical experiments and BioID pull-down would 
allow for validation of in vivo interactors.  
 114 
CHAPTER V. GENERAL DISCUSSION 
 
The aim of this thesis was to expand our knowledge about the maintenance DNA 
methyltransferase DNMT1, specifically with regard to its regulation by N-terminal domains of 
previously unknown function: the (GK) repeats and BAH domains.   
 Although recombinant DNMT1 protein was shown to efficiently methylate unmethylated 
DNA substrate in vitro (Okano et al. 1998; Yoder et al. 1997), its de novo methyltransferase 
activity has never been observed in vivo. In Chapter 2, I presented evidence showing that 
mutation of the (GK) repeats leads to de novo methylation at paternally imprinted DMRs. In 
particular, I found that cells expressing DNMT1 with unacetylatable arginines substituted for all 
lysine residues within the (GK) repeats acquire ectopic gain of methylation at paternally 
imprinted genes, while maternal imprints do not similarly acquire abnormal methylation. These 
data indicate that DNMT1 is capable of establishing de novo methylation at paternal imprinting 
control regions in vivo, and its de novo methyltransferase activity is inhibited by acetylation of 
the (GK) repeats. The observed gain of methylation has a functional effect and results in the 
change of the transcription of paternally imprinted genes, such as H19.  
 It is striking that ectopic methylation occurs exclusively at paternal imprinted control 
regions. Genetic studies of other DNA methyltransferases have not been clear about the 
establishment of paternal imprints in the male germline (Kaneda et al. 2004; Kato et al. 2007; 
Bourc'his & Bestor 2004). Based on these findings, we propose a new model in which DNMT1 
with unacetylated (GK) repeats is the enzyme responsible for the establishment of de novo 
methylation patterns at paternally imprinted genes in prospermatogonia. The similarity between 
histone H4 and the (GK) repeats raises the possibility that the two proteins could be acetylated 
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and deacetylated by the same enzymes (HAT/HDAC). Although the acetylation status of 
DNMT1 in germ cells is unknown, de novo methylation in prospermatogonia is pre-meiotic and 
precedes the wave of histone H4 acetylation that occurs in haploid spermatids (Meistrich et al. 
1992). 
The (GK) repeats of DNMT1 has previously been proposed to play a role in the stability 
of the protein through its interaction with the deubiquitinase USP7 (Cheng et al. 2015). Chapter 
3 aimed to test by genetic means the prevalent model stating that binding of the (GK) repeats to 
USP7 modulates DNMT1 levels during the cell cycle in an acetylation/ubiquitination-dependent 
manner (Du et al. 2010; Cheng et al. 2015). Contrary to the biochemical prediction, my genetic 
data demonstrated that USP7 deletion has no influence on DNMT1 protein levels and plays no 
regulatory role in maintenance DNA methylation. In addition, my data showed that USP7 
localization to replication foci is independent of DNMT1. Therefore, the significance of the 
physical interaction between USP7 and DNMT1 needs to be reexamined. 
 The data presented in Chapter 4 demonstrate that BAH domains of DNMT1 are required 
for its targeting to replication foci during S phase, and this targeting possibly involves interaction 
with histones. Using CRISPR/Cas9 technology, I generated a mutant of Dnmt1 that encodes a 
truncated DNMT1 protein with deleted BAH domains in mouse ES cells.  I found that the 
mutated protein is stable but mislocalized, which causes global genome demethylation. Hence, it 
can be concluded that the BAH domains target DNMT1 to the replication fork. Based on 
structural similarities with BAH domains of other proteins, it is likely that the BAH domains 
mediate protein-protein interactions. However the putative protein that binds to DNMT1’s BAH 
domains has not been identified.  In vitro studies using a histone peptide array and recombinant 
BAH domains, structural analysis and pull-down experiments identified BAH1 as a histone-
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binding domain. Further investigations are necessary to verify the significance of these newly 
found interactions in vivo.  
My doctoral work revealed that maintenance and de novo methylation activities are not as 
distinctly separated as previously thought. In fact, in vitro studies have shown that DNMT1 has 
greater affinity towards unmethylated DNA than de novo methyltransferases DNMT3A and 
DNMT3B (Okano et al. 1998). To date, all of the studied domains of DNMT1 were shown to be 
important for its maintenance activity (Leonhardt et al. 1992; Song et al. 2011). Our data 
identifies the (GK) repeats as the first known motif of DNMT1 that is important for its de novo 
methyltransferase function in vivo.  
Proper subcellular localization of DNMT1 during S phase is a crucial aspect of normal 
maintenance DNA methylation. It has been shown that the RFTS domain of DNMT1 is 
important for its targeting to replication foci (Leonhardt et al. 1992) and interaction with a co-
factor UHRF1(Bostick et al. 2007; Sharif et al. 2007).  Importantly, our study of the BAH 
domains identified a novel pathway for targeting DNMT1 to replication foci during S phase. 
Loss of either RFTS- or BAH-related targeting leads to mislocalization of DNMT1, suggesting 
that these mechanisms are not redundant. The fact that normal RFTS targeting cannot 
compensate for the disruption of the BAH domains, and vice versa, suggests that these targeting 
pathways act in a coordinated fashion. New studies propose that RFTS-dependent targeting to 
UHRF1 is dependent on the ubiquitination of histone H3 (H3K23 in Xenopus; H3K18 in 
mammals) (Nishiyama et al. 2013; Qin et al. 2015). It is possible that the histone-binding ability 
of BAH1 domain might be necessary for securing interactions with the nucleosome. 
Unexpectedly, DNMT1 has been found in a screen for proteins that bind to nucleosomes 
containing ubiquitinated H2A (Kalb et al. 2014). The combination of RFTS and BAH1 targeting 
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would provide a dual mode of recognition to ensure proper maintenance methylation. Further 
study of the mechanism of BAH targeting of DNMT1 is necessary to understand this interplay.  
The bulk of the mammalian genome is methylated, but cytosine methylation has a 
functional role only at certain sequences. Even though DNMT1 is the only known maintenance 
methyltransferase, it becomes increasingly clear that it possess different affinities and regulatory 
interactions at different genomic sequences. This thesis demonstrates that different domains of 
DNMT1 are required for methylation of different genomic compartments. The (GK) repeats 
motif plays no role in maintenance DNA methylation, though it is involved in the regulation of 
de novo methylation of paternal imprints. On the other hand, BAH domains are necessary for 
methylation of IAP retrotransposons and major satellites, while they are only partially required 




V.1. Further Perspectives 
The successful resolution of the DNMT1 crystal structure provides a platform from 
which to understand the mechanism of maintenance DNA methylation, along with the 
opportunity to study the functions of individual domains of the DNMT1 molecule as opposed to 
the loss-of-function genetics. In this thesis, I employed a strategy of studying the (GK) repeats 
and BAH domains by creating point mutations and deletions of domains within the endogenous 
protein. This technical approach allowed me to uncouple maintenance DNA methylation from 
other possible functions of DNMT1, and, as a result, I identified a novel de novo 
methyltransferase function of DNMT1 at paternally imprinted genes.  
Similar methodology could be applied to the study of other domains of DNMT1. For 
example, our understanding of CXXC function derives only from in vitro studies, where it has 
been shown that CXXC restricts the methylation activity of DNMT1 on unmethylated substrates 
in vitro (Song et al. 2011). It would be interesting to see how a point mutant of the CXXC 
domain behaves in vivo, and if DNMT1 is able to gain robust de novo activity by losing CXXC 
inhibition.  
Similarly, such an approach could be applied to the study of point mutations in the RFTS 
domain that cause DNMT1-complex disorder (Sun et al. 2014; Klein et al. 2013; Klein et al. 
2011; Baets et al. 2015). Better understanding of the functional consequences of DNMT1 
mutations could provide a possible cure and major life improvement for many patients that 
develop this autosomal dominant disorder in adulthood. Rapid development and application of 
CRISPR/Cas9 technology would be very helpful for carrying out precise genetic manipulations 
at the Dnmt1 locus and for the creation of a mouse model of the disease.  
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Dedicated studies of the mutations associated with the DNMT1-complex disorder would 
provide valuable insight into the enigmatic function of DNMT1 in post-mitotic neurons (Goto et 
al. 1994; Trasler et al. 1996), specifically in neuronal cytoplasm (Inano et al. 2000). Baets at el., 
2015 found that mutant DNMT1 proteins when overexpressed in HEK293 cells mislocalize and 
aggregate in the cytoplasm. This observation potentially provides a link between DNMT1-
complex disorder and the aggregative proteinopathies seen in many neurodegenerative disorders 
(Ross & Poirier 2004; Ciryam et al. 2013). The only other instance of cytoplasmic trafficking of 
DNMT1 known to occur is in the oocyte and in the cleavage-stage embryo(Howell et al. 2001).   
Our discovery of a novel pathway for the de novo methylation of paternal imprints by the 
unacetylated form of DNMT1 opens many questions in the field of imprinting and post-
translational modification of the methylation machinery. First, our model suggests that only the 
unacetylated form of DNMT1 present in prospermatogonia is capable of establishing de novo 
methylation at paternal imprints. Even low amounts of protein would be sufficient to perform 
this function at only three paternal DMRs. Regulation of acetylation/deacetylation and the 
specific HAT/HDAC enzymes required for this process should be further investigated. This 
especially raises the question of a potentially aberrant acetylation/deacetylation switch for 
DNMT1 function. It would be beneficial to investigate if other sequences, in addition, to 
paternally imprinted genes, could acquire ectopic methylation due to misregulation of DNMT1 
acetylation. This would be especially applicable to the study of cancer, where global 
hypomethylation is observed together with focal gains of ectopic methylation (Bestor 2003). No 
mutation in Dnmt1 has been identified as causative in cancer to date, but a defect in DNMT1’s 
acetylation/deacetylation could result from a mutation in other factors, such as HATs/HDACs.  
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Our model also broadens the already profound sexual dimorphism that surrounds the 
establishment of imprinting. Previously, it was thought that DNMT3A is involved in 
establishment of both maternal and paternal imprints, even though data regarding paternal 
imprints was not clear (Kaneda et al. 2004; Kato et al. 2007). In contrast, we propose, on the 
basis of our data, that two different enzymes and two distinct mechanisms are involved in 
paternal and maternal imprinting. Further investigation of the specific mechanism for the 
establishment of paternal imprints by the unacetylated form of DNMT1 would provide answers 
to some long-standing questions in the field, such as the distinction of maternal versus paternal 
differentially methylated sequences, establishment of complex imprinting systems and the origin 
of imprinting sequences in the mammalian genome.  
It is paradoxical that the maintenance methyltransferase DNMT1 does not possess an 
ability to recognize hemimethylated DNA directly and instead contains CXXC domain that 
recognizes unmethylated DNA. Mechanisms targeting DNMT1 to hemimethylated DNA and 
inhibiting it at unmethylated sequences have been discovered and culminate in DNMT1’s ability 
to replicate methylation patterns with great fidelity. However, these mechanisms do not 
completely prevent the enzyme’s innate affinity towards unmethylated DNA. Our discovery of 
de novo methyltransferase function of DNMT1 changes the paradigm and our understanding of 
the methylation machinery, where there was thought to be a strict division of roles in 
establishment versus maintenance methylation.  
Alignment of the (GK) repeats from DNMT1 homologues (Figure 1D) demonstrates an 
expansion of this motif with evolutionary progression. In Arabidopsis, there are two lysine-
glycine dipeptides, four in Bombyx, and seven in the mouse. Interestingly, Arabidopsis has been 
shown to utilize imprinting in the endosperm, a nutrient-supplying tissue (Raissig et al. 2013) 
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bearing resemblance to the mammalian placenta. It has been suggested that imprinting arose in 
mammals with the acquisition of the placenta, though some reptiles and insects possess a simpler 
placenta as well (Renfree et al. 2013). This observation raises a question about the emergence of 
the (GK) motif in species that possess genomic imprinting and DNA methylation and would 
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